Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Alliance for Regenerative Medicine to hold a virtual meeting » 04:55
04/09/21
04/09
04:55
04/09/21
04:55
BLUE

Bluebird Bio

$28.86 /

-1.2 (-3.99%)

, GILD

Gilead

$65.03 /

-0.56 (-0.85%)

, TMO

Thermo Fisher

$471.57 /

+5.26 (+1.13%)

, SGTX

Sigilon Therapeutics

$17.81 /

-0.5 (-2.73%)

, ADAP

Adaptimmune

$5.12 /

+0.16 (+3.23%)

, AGTC

Applied Genetic

$4.57 /

+0.115 (+2.58%)

, ATRA

Atara Biotherapeutics

$14.18 /

-0.035 (-0.25%)

, CABA

Cabaletta Bio

$10.77 /

+0.155 (+1.46%)

, FLXN

Flexion

$8.30 /

-0.03 (-0.36%)

, DTIL

Precision BioSciences

$8.94 /

+0.025 (+0.28%)

, DOV

Dover

$138.50 /

-0.465 (-0.33%)

, GNPX

Genprex

$4.88 /

+0.805 (+19.78%)

, DBTX

Decibel Therapeutics

$10.71 /

-0.35 (-3.16%)

, CYRX

Cryoport

$53.88 /

+2.68 (+5.23%)

, GLW

Corning

$44.57 /

+0.27 (+0.61%)

, FTV

Fortive

$70.23 /

-1.16 (-1.62%)

, KRYS

Krystal Biotech

$73.50 /

-0.25 (-0.34%)

, NVO

Novo Nordisk

$69.24 /

+1.375 (+2.03%)

, NVS

Novartis

$87.02 /

+0.705 (+0.82%)

, ORTX

Orchard Therapeutics

$6.96 /

+0.09 (+1.31%)

, MRK

Merck

$75.48 /

-0.65 (-0.85%)

, MEDP

Medpace

$169.50 /

+1.6 (+0.95%)

, IOVA

Iovance Biotherapeutics

$31.30 /

+0.31 (+1.00%)

, FOLD

Amicus

$9.27 /

-0.0999 (-1.07%)

Cell & Gene Virtual…

Cell & Gene Virtual Meeting on the Mediterranean will be held on April 6-9. Webcast Link

ShowHide Related Items >><<
TMO Thermo Fisher
$471.57 /

+5.26 (+1.13%)

SGTX Sigilon Therapeutics
$17.81 /

-0.5 (-2.73%)

ORTX Orchard Therapeutics
$6.96 /

+0.09 (+1.31%)

NVS Novartis
$87.02 /

+0.705 (+0.82%)

NVO Novo Nordisk
$69.24 /

+1.375 (+2.03%)

MRK Merck
$75.48 /

-0.65 (-0.85%)

KRYS Krystal Biotech
$73.50 /

-0.25 (-0.34%)

IOVA Iovance Biotherapeutics
$31.30 /

+0.31 (+1.00%)

GNPX Genprex
$4.88 /

+0.805 (+19.78%)

GLW Corning
$44.57 /

+0.27 (+0.61%)

GILD Gilead
$65.03 /

-0.56 (-0.85%)

FTV Fortive
$70.23 /

-1.16 (-1.62%)

FOLD Amicus
$9.27 /

-0.0999 (-1.07%)

FLXN Flexion
$8.30 /

-0.03 (-0.36%)

DTIL Precision BioSciences
$8.94 /

+0.025 (+0.28%)

DOV Dover
$138.50 /

-0.465 (-0.33%)

DBTX Decibel Therapeutics
$10.71 /

-0.35 (-3.16%)

CYRX Cryoport
$53.88 /

+2.68 (+5.23%)

CABA Cabaletta Bio
$10.77 /

+0.155 (+1.46%)

BLUE Bluebird Bio
$28.86 /

-1.2 (-3.99%)

ATRA Atara Biotherapeutics
$14.18 /

-0.035 (-0.25%)

AGTC Applied Genetic
$4.57 /

+0.115 (+2.58%)

ADAP Adaptimmune
$5.12 /

+0.16 (+3.23%)

BLUE Bluebird Bio
$28.86 /

-1.2 (-3.99%)

03/29/21 BMO Capital
Bluebird Bio price target raised to $35 from $31 at BMO Capital
03/29/21 Mizuho
Bluebird Bio approval could improve sentiment on shares, says Mizuho
03/29/21 Piper Sandler
Bluebird Bio price target raised to $35 from $30 at Piper Sandler
03/17/21 Stifel
Stifel says Bluebird Bio CMO exit 'a bit concerning but not thesis changing'
GILD Gilead
$65.03 /

-0.56 (-0.85%)

04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Bernstein
Gilead upgraded to Outperform from Market Perform at Bernstein
03/30/21 Redburn
Gilead upgraded to Buy from Neutral at Redburn
03/15/21 Mizuho
Merck's Gilead collaboration likely to broaden reach of islatravir, says Mizuho
TMO Thermo Fisher
$471.57 /

+5.26 (+1.13%)

03/29/21 UBS
Thermo Fisher price target lowered to $560 from $588 at UBS
03/18/21 KeyBanc
Thermo Fisher upgraded to Overweight at KeyBanc after Sartorius guidance
03/18/21 KeyBanc
Thermo Fisher upgraded to Overweight from Sector Weight at KeyBanc
03/02/21 Barclays
Thermo Fisher initiated with an Overweight at Barclays
SGTX Sigilon Therapeutics
$17.81 /

-0.5 (-2.73%)

12/29/20 Barclays
Sigilon Therapeutics initiated with an Overweight at Barclays
12/29/20 Morgan Stanley
Sigilon Therapeutics initiated with an Equal Weight at Morgan Stanley
12/29/20 Jefferies
Sigilon Therapeutics initiated with a Buy at Jefferies
ADAP Adaptimmune
$5.12 /

+0.16 (+3.23%)

08/12/20 Piper Sandler
TCR2 Therapeutics initiated with an Overweight at Piper Sandler
06/01/20 Mizuho
Adaptimmune price target raised to $9 from $3 at Mizuho
05/29/20 JonesTrading
JonesTrading upgrades Adaptimmune to Buy after data alleviates 'key concern'
05/29/20 JonesTrading
Adaptimmune upgraded to Buy from Hold at JonesTrading
AGTC Applied Genetic
$4.57 /

+0.115 (+2.58%)

03/01/21 Stifel
Applied Genetic initiated with a Buy at Stifel
02/02/21 H.C. Wainwright
Applied Genetic price target raised to $24 from $18 at H.C. Wainwright
02/01/21 Roth Capital
Applied Genetic price target raised to $35 from $30 at Roth Capital
11/17/20 Roth Capital
Applied Genetic price target raised to $30 from $26 at Roth Capital
ATRA Atara Biotherapeutics
$14.18 /

-0.035 (-0.25%)

03/25/21 Evercore ISI
Viracta Therapeutics initiated with an Outperform at Evercore ISI
03/02/21 Citi
Atara Biotherapeutics upgraded to Buy at Citi following 35% pullback
03/02/21 Citi
Atara Biotherapeutics upgraded to Buy from Neutral at Citi
01/04/21 Roth Capital
Roth keeps Buy rating on Atara Biotherapeutics after filing delay
CABA Cabaletta Bio
$10.77 /

+0.155 (+1.46%)

03/17/21 H.C. Wainwright
Cabaletta Bio price target raised to $22 from $20 at H.C. Wainwright
01/08/21 Chardan
Cabaletta Bio initiated with a Buy at Chardan
10/13/20 H.C. Wainwright
Cabaletta Bio initiated with a Buy at H.C. Wainwright
FLXN Flexion
$8.30 /

-0.03 (-0.36%)

04/06/21 RBC Capital
Flexion transferred with an Outperform at RBC Capital
08/20/20 Goldman Sachs
Flexion initiated with a Neutral at Goldman Sachs
07/30/20 Oppenheimer
Flexion initiated with an Outperform at Oppenheimer
07/29/20
Fly Intel: Top five analyst initiations
DTIL Precision BioSciences
$8.94 /

+0.025 (+0.28%)

04/06/21 Stifel
Stifel sees Precision BioSciences' CEO transition as 'disconcerting'
02/24/21
Fly Intel: Top five analyst initiations
02/24/21 JonesTrading
Precision BioSciences initiated with a Buy at JonesTrading
01/29/21 JPMorgan
Precision BioSciences price target raised to $14 from $10 at JPMorgan
DOV Dover
$138.50 /

-0.465 (-0.33%)

04/06/21 Barclays
Dover price target raised to $155 from $145 at Barclays
01/28/21 Baird
Dover price target raised to $147 from $140 at Baird
01/28/21 Baird
Dover results a solid beat with guidance above consensus, says Baird
01/05/21 Barclays
Dover price target raised to $141 from $138 at Barclays
GNPX Genprex
$4.88 /

+0.805 (+19.78%)

01/26/21 National Securities
Genprex initiated with a Buy at National Securities
04/22/20 Alliance Global Partners
Genprex initiated with a Buy at Alliance Global Partners
DBTX Decibel Therapeutics
$10.71 /

-0.35 (-3.16%)

03/09/21 Citi
Decibel Therapeutics initiated with a Buy at Citi
03/09/21 SVB Leerink
Decibel Therapeutics initiated with an Outperform at SVB Leerink
03/09/21 Barclays
Decibel Therapeutics initiated with an Overweight at Barclays
03/09/21 BMO Capital
Decibel Therapeutics initiated with an Outperform at BMO Capital
CYRX Cryoport
$53.88 /

+2.68 (+5.23%)

03/15/21
Fly Intel: Top five analyst initiations
03/15/21 UBS
Cryoport initiated with a Buy at UBS
03/02/21
Fly Intel: Top five analyst initiations
03/02/21 Needham
Cryoport assumed with a Buy at Needham
GLW Corning
$44.57 /

+0.27 (+0.61%)

04/07/21 Argus
Corning price target raised to $54 from $42 at Argus
01/28/21 Oppenheimer
Corning upgraded to Outperform from Perform at Oppenheimer
01/14/21 Barclays
Corning upgraded to Overweight with $44 target at Barclays
01/14/21 Barclays
Corning upgraded to Overweight from Equal Weight at Barclays
FTV Fortive
$70.23 /

-1.16 (-1.62%)

04/06/21 Barclays
Fortive price target raised to $73 from $72 at Barclays
02/17/21
Fly Intel: Top five analyst downgrades
02/17/21 Morgan Stanley
Fortive downgraded to Equal Weight at Morgan Stanley after re-rating
02/17/21 Morgan Stanley
Fortive downgraded to Equal Weight from Overweight at Morgan Stanley
KRYS Krystal Biotech
$73.50 /

-0.25 (-0.34%)

03/01/21 H.C. Wainwright
Krystal Biotech price target raised to $103 from $84 at H.C. Wainwright
03/01/21 William Blair
Krystal Biotech has 'catalyst-rich year ahead,' says William Blair
02/09/21 JonesTrading
Krystal Biotech initiated with a Buy at JonesTrading
01/15/21 Chardan
Krystal Biotech named a 'Top Pick for 2021' at Chardan
NVO Novo Nordisk
$69.24 /

+1.375 (+2.03%)

02/11/21 UBS
Novo Nordisk price target raised to DKK 425 from DKK 415 at UBS
02/04/21 Barclays
Novo Nordisk price target raised to DKK 495 from DKK 485 at Barclays
01/20/21 Citi
Citi opens 'Positive Catalyst Watch' on Novo Nordisk
01/20/21 Credit Suisse
Novo Nordisk downgraded to Neutral from Outperform at Credit Suisse
NVS Novartis
$87.02 /

+0.705 (+0.82%)

04/05/21 Morgan Stanley
Regenxbio AAV9 patent challenged by Passage Bio, says Morgan Stanley
03/23/21 Societe Generale
Novartis price target raised to CHF 107 from CHF 104 at Societe Generale
03/22/21 Bernstein
Novartis initiated with a Market Perform at Bernstein
03/10/21
Fly Intel: Top five analyst downgrades
ORTX Orchard Therapeutics
$6.96 /

+0.09 (+1.31%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/02/21 JPMorgan
Orchard Therapeutics assumed with an Overweight at JPMorgan
03/01/21 Stifel
Orchard Therapeutics initiated with a Buy at Stifel
02/18/21 Goldman Sachs
Orchard selloff on Bluebird Bio news overdone, says Goldman Sachs
MRK Merck
$75.48 /

-0.65 (-0.85%)

04/08/21 Alliance Global Partners
Alliance Global Partners sees Fast Track for Immutep efti as meaningful positive
04/08/21 H.C. Wainwright
Alkermes collaboration not as big as investors wanted, says H.C. Wainwright
04/07/21 Mizuho
Mizuho sees Alkermes, Merck collaboration as important next step for nemvaleukin
04/06/21 RBC Capital
Merck transferred with a Sector Perform at RBC Capital
MEDP Medpace
$169.50 /

+1.6 (+0.95%)

02/17/21 Truist
Medpace price target raised to $180 from $135 at Truist
02/16/21 Credit Suisse
Medpace price target raised to $178 from $155 at Credit Suisse
10/02/20 Truist
Medpace upgraded to Buy from Hold at Truist
07/29/20 Truist
Medpace price target raised to $124 from $95 at SunTrust
IOVA Iovance Biotherapeutics
$31.30 /

+0.31 (+1.00%)

03/08/21 H.C. Wainwright
Iovance Biotherapeutics upgraded to Buy from Neutral at H.C. Wainwright
01/29/21 Baird
Iovance Biotherapeutics assumed at Outperform at Baird
01/14/21 Oppenheimer
Iovance Biotherapeutics price target raised to $57 from $43 at Oppenheimer
12/17/20 Barclays
Iovance Biotherapeutics price target raised to $55 from $43 at Barclays
FOLD Amicus
$9.27 /

-0.0999 (-1.07%)

03/01/21 Stifel
Amicus initiated with a Hold at Stifel
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 JPMorgan
Amicus downgraded to Neutral on Pompe disease miss at JPMorgan
02/12/21 SVB Leerink
Amicus downgraded to Market Perform from Outperform at SVB Leerink
TMO Thermo Fisher
$471.57 /

+5.26 (+1.13%)

SGTX Sigilon Therapeutics
$17.81 /

-0.5 (-2.73%)

ORTX Orchard Therapeutics
$6.96 /

+0.09 (+1.31%)

NVS Novartis
$87.02 /

+0.705 (+0.82%)

NVO Novo Nordisk
$69.24 /

+1.375 (+2.03%)

MRK Merck
$75.48 /

-0.65 (-0.85%)

MEDP Medpace
$169.50 /

+1.6 (+0.95%)

KRYS Krystal Biotech
$73.50 /

-0.25 (-0.34%)

IOVA Iovance Biotherapeutics
$31.30 /

+0.31 (+1.00%)

GLW Corning
$44.57 /

+0.27 (+0.61%)

GILD Gilead
$65.03 /

-0.56 (-0.85%)

FTV Fortive
$70.23 /

-1.16 (-1.62%)

FOLD Amicus
$9.27 /

-0.0999 (-1.07%)

FLXN Flexion
$8.30 /

-0.03 (-0.36%)

DTIL Precision BioSciences
$8.94 /

+0.025 (+0.28%)

DOV Dover
$138.50 /

-0.465 (-0.33%)

CYRX Cryoport
$53.88 /

+2.68 (+5.23%)

CABA Cabaletta Bio
$10.77 /

+0.155 (+1.46%)

BLUE Bluebird Bio
$28.86 /

-1.2 (-3.99%)

ATRA Atara Biotherapeutics
$14.18 /

-0.035 (-0.25%)

AGTC Applied Genetic
$4.57 /

+0.115 (+2.58%)

ADAP Adaptimmune
$5.12 /

+0.16 (+3.23%)

  • 12
    Feb
  • 03
    Feb
  • 28
    Jan
  • 21
    Jan
  • 09
    Dec
  • 04
    Dec
  • 02
    Jun
  • 29
    May
  • 27
    May
  • 21
    May
  • 19
    May
  • 19
    May
TMO Thermo Fisher
$471.57 /

+5.26 (+1.13%)

NVS Novartis
$87.02 /

+0.705 (+0.82%)

MRK Merck
$75.48 /

-0.65 (-0.85%)

GLW Corning
$44.57 /

+0.27 (+0.61%)

GILD Gilead
$65.03 /

-0.56 (-0.85%)

FTV Fortive
$70.23 /

-1.16 (-1.62%)

FOLD Amicus
$9.27 /

-0.0999 (-1.07%)

CYRX Cryoport
$53.88 /

+2.68 (+5.23%)

BLUE Bluebird Bio
$28.86 /

-1.2 (-3.99%)

TMO Thermo Fisher
$471.57 /

+5.26 (+1.13%)

SGTX Sigilon Therapeutics
$17.81 /

-0.5 (-2.73%)

NVS Novartis
$87.02 /

+0.705 (+0.82%)

MRK Merck
$75.48 /

-0.65 (-0.85%)

GLW Corning
$44.57 /

+0.27 (+0.61%)

GILD Gilead
$65.03 /

-0.56 (-0.85%)

FOLD Amicus
$9.27 /

-0.0999 (-1.07%)

DTIL Precision BioSciences
$8.94 /

+0.025 (+0.28%)

DOV Dover
$138.50 /

-0.465 (-0.33%)

DBTX Decibel Therapeutics
$10.71 /

-0.35 (-3.16%)

BLUE Bluebird Bio
$28.86 /

-1.2 (-3.99%)

ATRA Atara Biotherapeutics
$14.18 /

-0.035 (-0.25%)

AGTC Applied Genetic
$4.57 /

+0.115 (+2.58%)

NVO Novo Nordisk
$69.24 /

+1.375 (+2.03%)

MRK Merck
$75.48 /

-0.65 (-0.85%)

GLW Corning
$44.57 /

+0.27 (+0.61%)

GILD Gilead
$65.03 /

-0.56 (-0.85%)

FOLD Amicus
$9.27 /

-0.0999 (-1.07%)

CABA Cabaletta Bio
$10.77 /

+0.155 (+1.46%)

BLUE Bluebird Bio
$28.86 /

-1.2 (-3.99%)

Thursday
Conference/Events
Alliance for Regenerative Medicine to hold a virtual meeting » 04:55
04/08/21
04/08
04:55
04/08/21
04:55
BLUE

Bluebird Bio

$30.06 /

-0.1 (-0.33%)

, GILD

Gilead

$65.59 /

-0.67 (-1.01%)

, TMO

Thermo Fisher

$466.27 /

-2.75 (-0.59%)

, SGTX

Sigilon Therapeutics

$18.35 /

-0.64 (-3.37%)

, ADAP

Adaptimmune

$4.96 /

-0.3 (-5.70%)

, AGTC

Applied Genetic

$4.45 /

-0.29 (-6.12%)

, ATRA

Atara Biotherapeutics

$14.22 /

+0.065 (+0.46%)

, CABA

Cabaletta Bio

$10.54 /

-1.02 (-8.82%)

, FLXN

Flexion

$8.34 /

-0.37 (-4.25%)

, DTIL

Precision BioSciences

$8.92 /

-0.34 (-3.67%)

, DOV

Dover

$139.17 /

-0.27 (-0.19%)

, GNPX

Genprex

$4.07 /

-0.23 (-5.35%)

, DBTX

Decibel Therapeutics

$11.06 /

-0.44 (-3.83%)

, CYRX

Cryoport

$51.23 /

-0.27 (-0.52%)

, GLW

Corning

$44.30 /

-0.38 (-0.85%)

, FTV

Fortive

$71.39 /

+0.25 (+0.35%)

, KRYS

Krystal Biotech

$73.72 /

-0.23 (-0.31%)

, NVO

Novo Nordisk

$67.86 /

-0.185 (-0.27%)

, NVS

Novartis

$86.30 /

-0.09 (-0.10%)

, ORTX

Orchard Therapeutics

$6.87 /

-0.22 (-3.10%)

, MRK

Merck

$76.13 /

+0.34 (+0.45%)

, MEDP

Medpace

$167.40 /

-7.13 (-4.09%)

, IOVA

Iovance Biotherapeutics

$31.02 /

-0.98 (-3.06%)

, FOLD

Amicus

$9.37 /

-0.19 (-1.99%)

Cell & Gene Virtual…

Cell & Gene Virtual Meeting on the Mediterranean will be held on April 6-9. Webcast Link

ShowHide Related Items >><<
TMO Thermo Fisher
$466.27 /

-2.75 (-0.59%)

SGTX Sigilon Therapeutics
$18.35 /

-0.64 (-3.37%)

ORTX Orchard Therapeutics
$6.87 /

-0.22 (-3.10%)

NVS Novartis
$86.30 /

-0.09 (-0.10%)

NVO Novo Nordisk
$67.86 /

-0.185 (-0.27%)

MRK Merck
$76.13 /

+0.34 (+0.45%)

KRYS Krystal Biotech
$73.72 /

-0.23 (-0.31%)

IOVA Iovance Biotherapeutics
$31.02 /

-0.98 (-3.06%)

GNPX Genprex
$4.07 /

-0.23 (-5.35%)

GLW Corning
$44.30 /

-0.38 (-0.85%)

GILD Gilead
$65.59 /

-0.67 (-1.01%)

FTV Fortive
$71.39 /

+0.25 (+0.35%)

FOLD Amicus
$9.37 /

-0.19 (-1.99%)

FLXN Flexion
$8.34 /

-0.37 (-4.25%)

DTIL Precision BioSciences
$8.92 /

-0.34 (-3.67%)

DOV Dover
$139.17 /

-0.27 (-0.19%)

DBTX Decibel Therapeutics
$11.06 /

-0.44 (-3.83%)

CYRX Cryoport
$51.23 /

-0.27 (-0.52%)

CABA Cabaletta Bio
$10.54 /

-1.02 (-8.82%)

BLUE Bluebird Bio
$30.06 /

-0.1 (-0.33%)

ATRA Atara Biotherapeutics
$14.22 /

+0.065 (+0.46%)

AGTC Applied Genetic
$4.45 /

-0.29 (-6.12%)

ADAP Adaptimmune
$4.96 /

-0.3 (-5.70%)

BLUE Bluebird Bio
$30.06 /

-0.1 (-0.33%)

03/29/21 BMO Capital
Bluebird Bio price target raised to $35 from $31 at BMO Capital
03/29/21 Mizuho
Bluebird Bio approval could improve sentiment on shares, says Mizuho
03/29/21 Piper Sandler
Bluebird Bio price target raised to $35 from $30 at Piper Sandler
03/17/21 Stifel
Stifel says Bluebird Bio CMO exit 'a bit concerning but not thesis changing'
GILD Gilead
$65.59 /

-0.67 (-1.01%)

04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Bernstein
Gilead upgraded to Outperform from Market Perform at Bernstein
03/30/21 Redburn
Gilead upgraded to Buy from Neutral at Redburn
03/15/21 Mizuho
Merck's Gilead collaboration likely to broaden reach of islatravir, says Mizuho
TMO Thermo Fisher
$466.27 /

-2.75 (-0.59%)

03/29/21 UBS
Thermo Fisher price target lowered to $560 from $588 at UBS
03/18/21 KeyBanc
Thermo Fisher upgraded to Overweight at KeyBanc after Sartorius guidance
03/18/21 KeyBanc
Thermo Fisher upgraded to Overweight from Sector Weight at KeyBanc
03/02/21 Barclays
Thermo Fisher initiated with an Overweight at Barclays
SGTX Sigilon Therapeutics
$18.35 /

-0.64 (-3.37%)

12/29/20 Barclays
Sigilon Therapeutics initiated with an Overweight at Barclays
12/29/20 Morgan Stanley
Sigilon Therapeutics initiated with an Equal Weight at Morgan Stanley
12/29/20 Jefferies
Sigilon Therapeutics initiated with a Buy at Jefferies
ADAP Adaptimmune
$4.96 /

-0.3 (-5.70%)

08/12/20 Piper Sandler
TCR2 Therapeutics initiated with an Overweight at Piper Sandler
06/01/20 Mizuho
Adaptimmune price target raised to $9 from $3 at Mizuho
05/29/20 JonesTrading
JonesTrading upgrades Adaptimmune to Buy after data alleviates 'key concern'
05/29/20 JonesTrading
Adaptimmune upgraded to Buy from Hold at JonesTrading
AGTC Applied Genetic
$4.45 /

-0.29 (-6.12%)

03/01/21 Stifel
Applied Genetic initiated with a Buy at Stifel
02/02/21 H.C. Wainwright
Applied Genetic price target raised to $24 from $18 at H.C. Wainwright
02/01/21 Roth Capital
Applied Genetic price target raised to $35 from $30 at Roth Capital
11/17/20 Roth Capital
Applied Genetic price target raised to $30 from $26 at Roth Capital
ATRA Atara Biotherapeutics
$14.22 /

+0.065 (+0.46%)

03/25/21 Evercore ISI
Viracta Therapeutics initiated with an Outperform at Evercore ISI
03/02/21 Citi
Atara Biotherapeutics upgraded to Buy at Citi following 35% pullback
03/02/21 Citi
Atara Biotherapeutics upgraded to Buy from Neutral at Citi
01/04/21 Roth Capital
Roth keeps Buy rating on Atara Biotherapeutics after filing delay
CABA Cabaletta Bio
$10.54 /

-1.02 (-8.82%)

03/17/21 H.C. Wainwright
Cabaletta Bio price target raised to $22 from $20 at H.C. Wainwright
01/08/21 Chardan
Cabaletta Bio initiated with a Buy at Chardan
10/13/20 H.C. Wainwright
Cabaletta Bio initiated with a Buy at H.C. Wainwright
FLXN Flexion
$8.34 /

-0.37 (-4.25%)

04/06/21 RBC Capital
Flexion transferred with an Outperform at RBC Capital
08/20/20 Goldman Sachs
Flexion initiated with a Neutral at Goldman Sachs
07/30/20 Oppenheimer
Flexion initiated with an Outperform at Oppenheimer
07/29/20
Fly Intel: Top five analyst initiations
DTIL Precision BioSciences
$8.92 /

-0.34 (-3.67%)

04/06/21 Stifel
Stifel sees Precision BioSciences' CEO transition as 'disconcerting'
02/24/21
Fly Intel: Top five analyst initiations
02/24/21 JonesTrading
Precision BioSciences initiated with a Buy at JonesTrading
01/29/21 JPMorgan
Precision BioSciences price target raised to $14 from $10 at JPMorgan
DOV Dover
$139.17 /

-0.27 (-0.19%)

04/06/21 Barclays
Dover price target raised to $155 from $145 at Barclays
01/28/21 Baird
Dover price target raised to $147 from $140 at Baird
01/28/21 Baird
Dover results a solid beat with guidance above consensus, says Baird
01/05/21 Barclays
Dover price target raised to $141 from $138 at Barclays
GNPX Genprex
$4.07 /

-0.23 (-5.35%)

01/26/21 National Securities
Genprex initiated with a Buy at National Securities
04/22/20 Alliance Global Partners
Genprex initiated with a Buy at Alliance Global Partners
DBTX Decibel Therapeutics
$11.06 /

-0.44 (-3.83%)

03/09/21 Citi
Decibel Therapeutics initiated with a Buy at Citi
03/09/21 SVB Leerink
Decibel Therapeutics initiated with an Outperform at SVB Leerink
03/09/21 Barclays
Decibel Therapeutics initiated with an Overweight at Barclays
03/09/21 BMO Capital
Decibel Therapeutics initiated with an Outperform at BMO Capital
CYRX Cryoport
$51.23 /

-0.27 (-0.52%)

03/15/21
Fly Intel: Top five analyst initiations
03/15/21 UBS
Cryoport initiated with a Buy at UBS
03/02/21
Fly Intel: Top five analyst initiations
03/02/21 Needham
Cryoport assumed with a Buy at Needham
GLW Corning
$44.30 /

-0.38 (-0.85%)

04/07/21 Argus
Corning price target raised to $54 from $42 at Argus
01/28/21 Oppenheimer
Corning upgraded to Outperform from Perform at Oppenheimer
01/14/21 Barclays
Corning upgraded to Overweight with $44 target at Barclays
01/14/21 Barclays
Corning upgraded to Overweight from Equal Weight at Barclays
FTV Fortive
$71.39 /

+0.25 (+0.35%)

04/06/21 Barclays
Fortive price target raised to $73 from $72 at Barclays
02/17/21
Fly Intel: Top five analyst downgrades
02/17/21 Morgan Stanley
Fortive downgraded to Equal Weight at Morgan Stanley after re-rating
02/17/21 Morgan Stanley
Fortive downgraded to Equal Weight from Overweight at Morgan Stanley
KRYS Krystal Biotech
$73.72 /

-0.23 (-0.31%)

03/01/21 H.C. Wainwright
Krystal Biotech price target raised to $103 from $84 at H.C. Wainwright
03/01/21 William Blair
Krystal Biotech has 'catalyst-rich year ahead,' says William Blair
02/09/21 JonesTrading
Krystal Biotech initiated with a Buy at JonesTrading
01/15/21 Chardan
Krystal Biotech named a 'Top Pick for 2021' at Chardan
NVO Novo Nordisk
$67.86 /

-0.185 (-0.27%)

02/11/21 UBS
Novo Nordisk price target raised to DKK 425 from DKK 415 at UBS
02/04/21 Barclays
Novo Nordisk price target raised to DKK 495 from DKK 485 at Barclays
01/20/21 Citi
Citi opens 'Positive Catalyst Watch' on Novo Nordisk
01/20/21 Credit Suisse
Novo Nordisk downgraded to Neutral from Outperform at Credit Suisse
NVS Novartis
$86.30 /

-0.09 (-0.10%)

04/05/21 Morgan Stanley
Regenxbio AAV9 patent challenged by Passage Bio, says Morgan Stanley
03/23/21 Societe Generale
Novartis price target raised to CHF 107 from CHF 104 at Societe Generale
03/22/21 Bernstein
Novartis initiated with a Market Perform at Bernstein
03/10/21
Fly Intel: Top five analyst downgrades
ORTX Orchard Therapeutics
$6.87 /

-0.22 (-3.10%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/02/21 JPMorgan
Orchard Therapeutics assumed with an Overweight at JPMorgan
03/01/21 Stifel
Orchard Therapeutics initiated with a Buy at Stifel
02/18/21 Goldman Sachs
Orchard selloff on Bluebird Bio news overdone, says Goldman Sachs
MRK Merck
$76.13 /

+0.34 (+0.45%)

04/07/21 Mizuho
Mizuho sees Alkermes, Merck collaboration as important next step for nemvaleukin
04/06/21 RBC Capital
Merck transferred with a Sector Perform at RBC Capital
04/01/21 Morgan Stanley
Merck cancer pipeline underappreciated and 'set to flow,' says Morgan Stanley
MEDP Medpace
$167.40 /

-7.13 (-4.09%)

02/17/21 Truist
Medpace price target raised to $180 from $135 at Truist
02/16/21 Credit Suisse
Medpace price target raised to $178 from $155 at Credit Suisse
10/02/20 Truist
Medpace upgraded to Buy from Hold at Truist
07/29/20 Truist
Medpace price target raised to $124 from $95 at SunTrust
IOVA Iovance Biotherapeutics
$31.02 /

-0.98 (-3.06%)

03/08/21 H.C. Wainwright
Iovance Biotherapeutics upgraded to Buy from Neutral at H.C. Wainwright
01/29/21 Baird
Iovance Biotherapeutics assumed at Outperform at Baird
01/14/21 Oppenheimer
Iovance Biotherapeutics price target raised to $57 from $43 at Oppenheimer
12/17/20 Barclays
Iovance Biotherapeutics price target raised to $55 from $43 at Barclays
FOLD Amicus
$9.37 /

-0.19 (-1.99%)

03/01/21 Stifel
Amicus initiated with a Hold at Stifel
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 JPMorgan
Amicus downgraded to Neutral on Pompe disease miss at JPMorgan
02/12/21 SVB Leerink
Amicus downgraded to Market Perform from Outperform at SVB Leerink
TMO Thermo Fisher
$466.27 /

-2.75 (-0.59%)

SGTX Sigilon Therapeutics
$18.35 /

-0.64 (-3.37%)

ORTX Orchard Therapeutics
$6.87 /

-0.22 (-3.10%)

NVS Novartis
$86.30 /

-0.09 (-0.10%)

NVO Novo Nordisk
$67.86 /

-0.185 (-0.27%)

MRK Merck
$76.13 /

+0.34 (+0.45%)

MEDP Medpace
$167.40 /

-7.13 (-4.09%)

KRYS Krystal Biotech
$73.72 /

-0.23 (-0.31%)

IOVA Iovance Biotherapeutics
$31.02 /

-0.98 (-3.06%)

GLW Corning
$44.30 /

-0.38 (-0.85%)

GILD Gilead
$65.59 /

-0.67 (-1.01%)

FTV Fortive
$71.39 /

+0.25 (+0.35%)

FOLD Amicus
$9.37 /

-0.19 (-1.99%)

FLXN Flexion
$8.34 /

-0.37 (-4.25%)

DTIL Precision BioSciences
$8.92 /

-0.34 (-3.67%)

DOV Dover
$139.17 /

-0.27 (-0.19%)

CYRX Cryoport
$51.23 /

-0.27 (-0.52%)

CABA Cabaletta Bio
$10.54 /

-1.02 (-8.82%)

BLUE Bluebird Bio
$30.06 /

-0.1 (-0.33%)

ATRA Atara Biotherapeutics
$14.22 /

+0.065 (+0.46%)

AGTC Applied Genetic
$4.45 /

-0.29 (-6.12%)

ADAP Adaptimmune
$4.96 /

-0.3 (-5.70%)

  • 12
    Feb
  • 03
    Feb
  • 28
    Jan
  • 21
    Jan
  • 09
    Dec
  • 04
    Dec
  • 02
    Jun
  • 29
    May
  • 27
    May
  • 21
    May
  • 19
    May
  • 19
    May
TMO Thermo Fisher
$466.27 /

-2.75 (-0.59%)

NVS Novartis
$86.30 /

-0.09 (-0.10%)

MRK Merck
$76.13 /

+0.34 (+0.45%)

GLW Corning
$44.30 /

-0.38 (-0.85%)

GILD Gilead
$65.59 /

-0.67 (-1.01%)

FTV Fortive
$71.39 /

+0.25 (+0.35%)

FOLD Amicus
$9.37 /

-0.19 (-1.99%)

CYRX Cryoport
$51.23 /

-0.27 (-0.52%)

BLUE Bluebird Bio
$30.06 /

-0.1 (-0.33%)

TMO Thermo Fisher
$466.27 /

-2.75 (-0.59%)

SGTX Sigilon Therapeutics
$18.35 /

-0.64 (-3.37%)

NVS Novartis
$86.30 /

-0.09 (-0.10%)

MRK Merck
$76.13 /

+0.34 (+0.45%)

GLW Corning
$44.30 /

-0.38 (-0.85%)

GILD Gilead
$65.59 /

-0.67 (-1.01%)

FOLD Amicus
$9.37 /

-0.19 (-1.99%)

DTIL Precision BioSciences
$8.92 /

-0.34 (-3.67%)

DOV Dover
$139.17 /

-0.27 (-0.19%)

DBTX Decibel Therapeutics
$11.06 /

-0.44 (-3.83%)

BLUE Bluebird Bio
$30.06 /

-0.1 (-0.33%)

ATRA Atara Biotherapeutics
$14.22 /

+0.065 (+0.46%)

AGTC Applied Genetic
$4.45 /

-0.29 (-6.12%)

NVO Novo Nordisk
$67.86 /

-0.185 (-0.27%)

MRK Merck
$76.13 /

+0.34 (+0.45%)

GLW Corning
$44.30 /

-0.38 (-0.85%)

GILD Gilead
$65.59 /

-0.67 (-1.01%)

FOLD Amicus
$9.37 /

-0.19 (-1.99%)

CABA Cabaletta Bio
$10.54 /

-1.02 (-8.82%)

BLUE Bluebird Bio
$30.06 /

-0.1 (-0.33%)

Wednesday
Conference/Events
Alliance for Regenerative Medicine to hold a virtual meeting » 04:55
04/07/21
04/07
04:55
04/07/21
04:55
BLUE

Bluebird Bio

$30.15 /

-0.95 (-3.05%)

, GILD

Gilead

$66.26 /

-0.09 (-0.14%)

, TMO

Thermo Fisher

$469.09 /

+3.53 (+0.76%)

, SGTX

Sigilon Therapeutics

$19.05 /

-0.965 (-4.82%)

, ADAP

Adaptimmune

$5.26 /

-0.35 (-6.24%)

, AGTC

Applied Genetic

$4.74 /

-0.26 (-5.20%)

, ATRA

Atara Biotherapeutics

$14.15 /

-0.53 (-3.61%)

, CABA

Cabaletta Bio

$11.21 /

-0.4 (-3.45%)

, FLXN

Flexion

$8.71 /

-0.11 (-1.25%)

, DTIL

Precision BioSciences

$9.23 /

-1.24 (-11.84%)

, DOV

Dover

$139.44 /

-0.74 (-0.53%)

, GNPX

Genprex

$4.29 /

+0.06 (+1.42%)

, DBTX

Decibel Therapeutics

$11.48 /

+0.09 (+0.79%)

, CYRX

Cryoport

$51.47 /

+1.1 (+2.18%)

, GLW

Corning

$44.68 /

-0.81 (-1.78%)

, FTV

Fortive

$71.18 /

-0.78 (-1.08%)

, KRYS

Krystal Biotech

$74.13 /

-4.6 (-5.84%)

, NVO

Novo Nordisk

$68.05 /

-0.235 (-0.34%)

, NVS

Novartis

$86.40 /

-0.89 (-1.02%)

, ORTX

Orchard Therapeutics

$7.09 /

-0.14 (-1.94%)

, MRK

Merck

$75.79 /

-1.21 (-1.57%)

, MEDP

Medpace

$171.71 /

+0.78 (+0.46%)

, IOVA

Iovance Biotherapeutics

$31.99 /

-0.16 (-0.50%)

, FOLD

Amicus

$9.56 /

-0.3848 (-3.87%)

Cell & Gene Virtual…

Cell & Gene Virtual Meeting on the Mediterranean will be held on April 6-9. Webcast Link

ShowHide Related Items >><<
TMO Thermo Fisher
$469.09 /

+3.53 (+0.76%)

SGTX Sigilon Therapeutics
$19.05 /

-0.965 (-4.82%)

ORTX Orchard Therapeutics
$7.09 /

-0.14 (-1.94%)

NVS Novartis
$86.40 /

-0.89 (-1.02%)

NVO Novo Nordisk
$68.05 /

-0.235 (-0.34%)

MRK Merck
$75.79 /

-1.21 (-1.57%)

KRYS Krystal Biotech
$74.13 /

-4.6 (-5.84%)

IOVA Iovance Biotherapeutics
$31.99 /

-0.16 (-0.50%)

GNPX Genprex
$4.29 /

+0.06 (+1.42%)

GLW Corning
$44.68 /

-0.81 (-1.78%)

GILD Gilead
$66.26 /

-0.09 (-0.14%)

FTV Fortive
$71.18 /

-0.78 (-1.08%)

FOLD Amicus
$9.56 /

-0.3848 (-3.87%)

FLXN Flexion
$8.71 /

-0.11 (-1.25%)

DTIL Precision BioSciences
$9.23 /

-1.24 (-11.84%)

DOV Dover
$139.44 /

-0.74 (-0.53%)

DBTX Decibel Therapeutics
$11.48 /

+0.09 (+0.79%)

CYRX Cryoport
$51.47 /

+1.1 (+2.18%)

CABA Cabaletta Bio
$11.21 /

-0.4 (-3.45%)

BLUE Bluebird Bio
$30.15 /

-0.95 (-3.05%)

ATRA Atara Biotherapeutics
$14.15 /

-0.53 (-3.61%)

AGTC Applied Genetic
$4.74 /

-0.26 (-5.20%)

ADAP Adaptimmune
$5.26 /

-0.35 (-6.24%)

BLUE Bluebird Bio
$30.15 /

-0.95 (-3.05%)

03/29/21 BMO Capital
Bluebird Bio price target raised to $35 from $31 at BMO Capital
03/29/21 Mizuho
Bluebird Bio approval could improve sentiment on shares, says Mizuho
03/29/21 Piper Sandler
Bluebird Bio price target raised to $35 from $30 at Piper Sandler
03/17/21 Stifel
Stifel says Bluebird Bio CMO exit 'a bit concerning but not thesis changing'
GILD Gilead
$66.26 /

-0.09 (-0.14%)

04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Bernstein
Gilead upgraded to Outperform from Market Perform at Bernstein
03/30/21 Redburn
Gilead upgraded to Buy from Neutral at Redburn
03/15/21 Mizuho
Merck's Gilead collaboration likely to broaden reach of islatravir, says Mizuho
TMO Thermo Fisher
$469.09 /

+3.53 (+0.76%)

03/29/21 UBS
Thermo Fisher price target lowered to $560 from $588 at UBS
03/18/21 KeyBanc
Thermo Fisher upgraded to Overweight at KeyBanc after Sartorius guidance
03/18/21 KeyBanc
Thermo Fisher upgraded to Overweight from Sector Weight at KeyBanc
03/02/21 Barclays
Thermo Fisher initiated with an Overweight at Barclays
SGTX Sigilon Therapeutics
$19.05 /

-0.965 (-4.82%)

12/29/20 Barclays
Sigilon Therapeutics initiated with an Overweight at Barclays
12/29/20 Morgan Stanley
Sigilon Therapeutics initiated with an Equal Weight at Morgan Stanley
12/29/20 Jefferies
Sigilon Therapeutics initiated with a Buy at Jefferies
ADAP Adaptimmune
$5.26 /

-0.35 (-6.24%)

08/12/20 Piper Sandler
TCR2 Therapeutics initiated with an Overweight at Piper Sandler
06/01/20 Mizuho
Adaptimmune price target raised to $9 from $3 at Mizuho
05/29/20 JonesTrading
JonesTrading upgrades Adaptimmune to Buy after data alleviates 'key concern'
05/29/20 JonesTrading
Adaptimmune upgraded to Buy from Hold at JonesTrading
AGTC Applied Genetic
$4.74 /

-0.26 (-5.20%)

03/01/21 Stifel
Applied Genetic initiated with a Buy at Stifel
02/02/21 H.C. Wainwright
Applied Genetic price target raised to $24 from $18 at H.C. Wainwright
02/01/21 Roth Capital
Applied Genetic price target raised to $35 from $30 at Roth Capital
11/17/20 Roth Capital
Applied Genetic price target raised to $30 from $26 at Roth Capital
ATRA Atara Biotherapeutics
$14.15 /

-0.53 (-3.61%)

03/25/21 Evercore ISI
Viracta Therapeutics initiated with an Outperform at Evercore ISI
03/02/21 Citi
Atara Biotherapeutics upgraded to Buy at Citi following 35% pullback
03/02/21 Citi
Atara Biotherapeutics upgraded to Buy from Neutral at Citi
01/04/21 Roth Capital
Roth keeps Buy rating on Atara Biotherapeutics after filing delay
CABA Cabaletta Bio
$11.21 /

-0.4 (-3.45%)

03/17/21 H.C. Wainwright
Cabaletta Bio price target raised to $22 from $20 at H.C. Wainwright
01/08/21 Chardan
Cabaletta Bio initiated with a Buy at Chardan
10/13/20 H.C. Wainwright
Cabaletta Bio initiated with a Buy at H.C. Wainwright
FLXN Flexion
$8.71 /

-0.11 (-1.25%)

04/06/21 RBC Capital
Flexion transferred with an Outperform at RBC Capital
08/20/20 Goldman Sachs
Flexion initiated with a Neutral at Goldman Sachs
07/30/20 Oppenheimer
Flexion initiated with an Outperform at Oppenheimer
07/29/20
Fly Intel: Top five analyst initiations
DTIL Precision BioSciences
$9.23 /

-1.24 (-11.84%)

04/06/21 Stifel
Stifel sees Precision BioSciences' CEO transition as 'disconcerting'
02/24/21
Fly Intel: Top five analyst initiations
02/24/21 JonesTrading
Precision BioSciences initiated with a Buy at JonesTrading
01/29/21 JPMorgan
Precision BioSciences price target raised to $14 from $10 at JPMorgan
DOV Dover
$139.44 /

-0.74 (-0.53%)

04/06/21 Barclays
Dover price target raised to $155 from $145 at Barclays
01/28/21 Baird
Dover price target raised to $147 from $140 at Baird
01/28/21 Baird
Dover results a solid beat with guidance above consensus, says Baird
01/05/21 Barclays
Dover price target raised to $141 from $138 at Barclays
GNPX Genprex
$4.29 /

+0.06 (+1.42%)

01/26/21 National Securities
Genprex initiated with a Buy at National Securities
04/22/20 Alliance Global Partners
Genprex initiated with a Buy at Alliance Global Partners
DBTX Decibel Therapeutics
$11.48 /

+0.09 (+0.79%)

03/09/21 Citi
Decibel Therapeutics initiated with a Buy at Citi
03/09/21 SVB Leerink
Decibel Therapeutics initiated with an Outperform at SVB Leerink
03/09/21 Barclays
Decibel Therapeutics initiated with an Overweight at Barclays
03/09/21 BMO Capital
Decibel Therapeutics initiated with an Outperform at BMO Capital
CYRX Cryoport
$51.47 /

+1.1 (+2.18%)

03/15/21
Fly Intel: Top five analyst initiations
03/15/21 UBS
Cryoport initiated with a Buy at UBS
03/02/21
Fly Intel: Top five analyst initiations
03/02/21 Needham
Cryoport assumed with a Buy at Needham
GLW Corning
$44.68 /

-0.81 (-1.78%)

01/28/21 Oppenheimer
Corning upgraded to Outperform from Perform at Oppenheimer
01/14/21 Barclays
Corning upgraded to Overweight with $44 target at Barclays
01/14/21 Barclays
Corning upgraded to Overweight from Equal Weight at Barclays
01/06/21
Fly Intel: Top five analyst initiations
FTV Fortive
$71.18 /

-0.78 (-1.08%)

04/06/21 Barclays
Fortive price target raised to $73 from $72 at Barclays
02/17/21
Fly Intel: Top five analyst downgrades
02/17/21 Morgan Stanley
Fortive downgraded to Equal Weight at Morgan Stanley after re-rating
02/17/21 Morgan Stanley
Fortive downgraded to Equal Weight from Overweight at Morgan Stanley
KRYS Krystal Biotech
$74.13 /

-4.6 (-5.84%)

03/01/21 H.C. Wainwright
Krystal Biotech price target raised to $103 from $84 at H.C. Wainwright
03/01/21 William Blair
Krystal Biotech has 'catalyst-rich year ahead,' says William Blair
02/09/21 JonesTrading
Krystal Biotech initiated with a Buy at JonesTrading
01/15/21 Chardan
Krystal Biotech named a 'Top Pick for 2021' at Chardan
NVO Novo Nordisk
$68.05 /

-0.235 (-0.34%)

02/11/21 UBS
Novo Nordisk price target raised to DKK 425 from DKK 415 at UBS
02/04/21 Barclays
Novo Nordisk price target raised to DKK 495 from DKK 485 at Barclays
01/20/21 Citi
Citi opens 'Positive Catalyst Watch' on Novo Nordisk
01/20/21 Credit Suisse
Novo Nordisk downgraded to Neutral from Outperform at Credit Suisse
NVS Novartis
$86.40 /

-0.89 (-1.02%)

04/05/21 Morgan Stanley
Regenxbio AAV9 patent challenged by Passage Bio, says Morgan Stanley
03/23/21 Societe Generale
Novartis price target raised to CHF 107 from CHF 104 at Societe Generale
03/22/21 Bernstein
Novartis initiated with a Market Perform at Bernstein
03/10/21
Fly Intel: Top five analyst downgrades
ORTX Orchard Therapeutics
$7.09 /

-0.14 (-1.94%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/02/21 JPMorgan
Orchard Therapeutics assumed with an Overweight at JPMorgan
03/01/21 Stifel
Orchard Therapeutics initiated with a Buy at Stifel
02/18/21 Goldman Sachs
Orchard selloff on Bluebird Bio news overdone, says Goldman Sachs
MRK Merck
$75.79 /

-1.21 (-1.57%)

04/06/21 RBC Capital
Merck transferred with a Sector Perform at RBC Capital
04/01/21 Morgan Stanley
Merck cancer pipeline underappreciated and 'set to flow,' says Morgan Stanley
03/15/21 Piper Sandler
Gilead pact with Merck can bring HIV sustainability, says Piper Sandler
MEDP Medpace
$171.71 /

+0.78 (+0.46%)

02/17/21 Truist
Medpace price target raised to $180 from $135 at Truist
02/16/21 Credit Suisse
Medpace price target raised to $178 from $155 at Credit Suisse
10/02/20 Truist
Medpace upgraded to Buy from Hold at Truist
07/29/20 Truist
Medpace price target raised to $124 from $95 at SunTrust
IOVA Iovance Biotherapeutics
$31.99 /

-0.16 (-0.50%)

03/08/21 H.C. Wainwright
Iovance Biotherapeutics upgraded to Buy from Neutral at H.C. Wainwright
01/29/21 Baird
Iovance Biotherapeutics assumed at Outperform at Baird
01/14/21 Oppenheimer
Iovance Biotherapeutics price target raised to $57 from $43 at Oppenheimer
12/17/20 Barclays
Iovance Biotherapeutics price target raised to $55 from $43 at Barclays
FOLD Amicus
$9.56 /

-0.3848 (-3.87%)

03/01/21 Stifel
Amicus initiated with a Hold at Stifel
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 JPMorgan
Amicus downgraded to Neutral on Pompe disease miss at JPMorgan
02/12/21 SVB Leerink
Amicus downgraded to Market Perform from Outperform at SVB Leerink
TMO Thermo Fisher
$469.09 /

+3.53 (+0.76%)

SGTX Sigilon Therapeutics
$19.05 /

-0.965 (-4.82%)

ORTX Orchard Therapeutics
$7.09 /

-0.14 (-1.94%)

NVS Novartis
$86.40 /

-0.89 (-1.02%)

NVO Novo Nordisk
$68.05 /

-0.235 (-0.34%)

MRK Merck
$75.79 /

-1.21 (-1.57%)

MEDP Medpace
$171.71 /

+0.78 (+0.46%)

KRYS Krystal Biotech
$74.13 /

-4.6 (-5.84%)

IOVA Iovance Biotherapeutics
$31.99 /

-0.16 (-0.50%)

GLW Corning
$44.68 /

-0.81 (-1.78%)

GILD Gilead
$66.26 /

-0.09 (-0.14%)

FTV Fortive
$71.18 /

-0.78 (-1.08%)

FOLD Amicus
$9.56 /

-0.3848 (-3.87%)

FLXN Flexion
$8.71 /

-0.11 (-1.25%)

DTIL Precision BioSciences
$9.23 /

-1.24 (-11.84%)

DOV Dover
$139.44 /

-0.74 (-0.53%)

CYRX Cryoport
$51.47 /

+1.1 (+2.18%)

CABA Cabaletta Bio
$11.21 /

-0.4 (-3.45%)

BLUE Bluebird Bio
$30.15 /

-0.95 (-3.05%)

ATRA Atara Biotherapeutics
$14.15 /

-0.53 (-3.61%)

AGTC Applied Genetic
$4.74 /

-0.26 (-5.20%)

ADAP Adaptimmune
$5.26 /

-0.35 (-6.24%)

  • 12
    Feb
  • 03
    Feb
  • 28
    Jan
  • 21
    Jan
  • 09
    Dec
  • 04
    Dec
  • 02
    Jun
  • 29
    May
  • 27
    May
  • 21
    May
  • 19
    May
  • 19
    May
TMO Thermo Fisher
$469.09 /

+3.53 (+0.76%)

NVS Novartis
$86.40 /

-0.89 (-1.02%)

MRK Merck
$75.79 /

-1.21 (-1.57%)

GLW Corning
$44.68 /

-0.81 (-1.78%)

GILD Gilead
$66.26 /

-0.09 (-0.14%)

FTV Fortive
$71.18 /

-0.78 (-1.08%)

FOLD Amicus
$9.56 /

-0.3848 (-3.87%)

CYRX Cryoport
$51.47 /

+1.1 (+2.18%)

BLUE Bluebird Bio
$30.15 /

-0.95 (-3.05%)

TMO Thermo Fisher
$469.09 /

+3.53 (+0.76%)

SGTX Sigilon Therapeutics
$19.05 /

-0.965 (-4.82%)

NVS Novartis
$86.40 /

-0.89 (-1.02%)

MRK Merck
$75.79 /

-1.21 (-1.57%)

GLW Corning
$44.68 /

-0.81 (-1.78%)

GILD Gilead
$66.26 /

-0.09 (-0.14%)

FOLD Amicus
$9.56 /

-0.3848 (-3.87%)

DTIL Precision BioSciences
$9.23 /

-1.24 (-11.84%)

DOV Dover
$139.44 /

-0.74 (-0.53%)

DBTX Decibel Therapeutics
$11.48 /

+0.09 (+0.79%)

BLUE Bluebird Bio
$30.15 /

-0.95 (-3.05%)

ATRA Atara Biotherapeutics
$14.15 /

-0.53 (-3.61%)

AGTC Applied Genetic
$4.74 /

-0.26 (-5.20%)

NVO Novo Nordisk
$68.05 /

-0.235 (-0.34%)

MRK Merck
$75.79 /

-1.21 (-1.57%)

IOVA Iovance Biotherapeutics
$31.99 /

-0.16 (-0.50%)

GLW Corning
$44.68 /

-0.81 (-1.78%)

GILD Gilead
$66.26 /

-0.09 (-0.14%)

FOLD Amicus
$9.56 /

-0.3848 (-3.87%)

CABA Cabaletta Bio
$11.21 /

-0.4 (-3.45%)

BLUE Bluebird Bio
$30.15 /

-0.95 (-3.05%)

Tuesday
Conference/Events
Alliance for Regenerative Medicine to hold a virtual meeting » 09:55
04/06/21
04/06
09:55
04/06/21
09:55
BLUE

Bluebird Bio

$30.45 /

-0.65 (-2.09%)

, GILD

Gilead

$66.10 /

-0.25 (-0.38%)

, TMO

Thermo Fisher

$465.69 /

+0.13 (+0.03%)

, SGTX

Sigilon Therapeutics

$20.04 /

+0.02 (+0.10%)

, ADAP

Adaptimmune

$5.58 /

-0.03 (-0.53%)

, AGTC

Applied Genetic

$4.95 /

-0.05 (-1.00%)

, ATRA

Atara Biotherapeutics

$14.68 /

+ (+0.00%)

, CABA

Cabaletta Bio

$11.61 /

+ (+0.00%)

, FLXN

Flexion

$8.65 /

-0.17 (-1.93%)

, DTIL

Precision BioSciences

$10.30 /

-0.17 (-1.62%)

, DOV

Dover

$140.45 /

+0.27 (+0.19%)

, GNPX

Genprex

$4.14 /

-0.09 (-2.13%)

, DBTX

Decibel Therapeutics

$11.36 /

-0.03 (-0.26%)

, CYRX

Cryoport

$50.71 /

+0.34 (+0.68%)

, GLW

Corning

$45.30 /

-0.19 (-0.42%)

, FTV

Fortive

$72.04 /

+0.08 (+0.11%)

, KRYS

Krystal Biotech

$78.76 /

+0.03 (+0.04%)

, NVO

Novo Nordisk

$68.09 /

-0.19 (-0.28%)

, NVS

Novartis

$87.06 /

-0.23 (-0.26%)

, ORTX

Orchard Therapeutics

$7.19 /

-0.04 (-0.55%)

, MRK

Merck

$76.44 /

-0.56 (-0.73%)

, MEDP

Medpace

$173.03 /

+2.1 (+1.23%)

, IOVA

Iovance Biotherapeutics

$31.80 /

-0.35 (-1.09%)

, FOLD

Amicus

$9.89 /

-0.055 (-0.55%)

Cell & Gene Virtual…

Cell & Gene Virtual Meeting on the Mediterranean will be held on April 6-9. Webcast Link

ShowHide Related Items >><<
TMO Thermo Fisher
$465.69 /

+0.13 (+0.03%)

SGTX Sigilon Therapeutics
$20.04 /

+0.02 (+0.10%)

ORTX Orchard Therapeutics
$7.19 /

-0.04 (-0.55%)

NVS Novartis
$87.06 /

-0.23 (-0.26%)

NVO Novo Nordisk
$68.09 /

-0.19 (-0.28%)

MRK Merck
$76.44 /

-0.56 (-0.73%)

KRYS Krystal Biotech
$78.76 /

+0.03 (+0.04%)

IOVA Iovance Biotherapeutics
$31.80 /

-0.35 (-1.09%)

GNPX Genprex
$4.14 /

-0.09 (-2.13%)

GLW Corning
$45.30 /

-0.19 (-0.42%)

GILD Gilead
$66.10 /

-0.25 (-0.38%)

FTV Fortive
$72.04 /

+0.08 (+0.11%)

FOLD Amicus
$9.89 /

-0.055 (-0.55%)

FLXN Flexion
$8.65 /

-0.17 (-1.93%)

DTIL Precision BioSciences
$10.30 /

-0.17 (-1.62%)

DOV Dover
$140.45 /

+0.27 (+0.19%)

DBTX Decibel Therapeutics
$11.36 /

-0.03 (-0.26%)

CYRX Cryoport
$50.71 /

+0.34 (+0.68%)

CABA Cabaletta Bio
$11.61 /

+ (+0.00%)

BLUE Bluebird Bio
$30.45 /

-0.65 (-2.09%)

ATRA Atara Biotherapeutics
$14.68 /

+ (+0.00%)

AGTC Applied Genetic
$4.95 /

-0.05 (-1.00%)

ADAP Adaptimmune
$5.58 /

-0.03 (-0.53%)

BLUE Bluebird Bio
$30.45 /

-0.65 (-2.09%)

03/29/21 BMO Capital
Bluebird Bio price target raised to $35 from $31 at BMO Capital
03/29/21 Mizuho
Bluebird Bio approval could improve sentiment on shares, says Mizuho
03/29/21 Piper Sandler
Bluebird Bio price target raised to $35 from $30 at Piper Sandler
03/17/21 Stifel
Stifel says Bluebird Bio CMO exit 'a bit concerning but not thesis changing'
GILD Gilead
$66.10 /

-0.25 (-0.38%)

04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Bernstein
Gilead upgraded to Outperform from Market Perform at Bernstein
03/30/21 Redburn
Gilead upgraded to Buy from Neutral at Redburn
03/15/21 Mizuho
Merck's Gilead collaboration likely to broaden reach of islatravir, says Mizuho
TMO Thermo Fisher
$465.69 /

+0.13 (+0.03%)

03/29/21 UBS
Thermo Fisher price target lowered to $560 from $588 at UBS
03/18/21 KeyBanc
Thermo Fisher upgraded to Overweight at KeyBanc after Sartorius guidance
03/18/21 KeyBanc
Thermo Fisher upgraded to Overweight from Sector Weight at KeyBanc
03/02/21 Barclays
Thermo Fisher initiated with an Overweight at Barclays
SGTX Sigilon Therapeutics
$20.04 /

+0.02 (+0.10%)

12/29/20 Barclays
Sigilon Therapeutics initiated with an Overweight at Barclays
12/29/20 Morgan Stanley
Sigilon Therapeutics initiated with an Equal Weight at Morgan Stanley
12/29/20 Jefferies
Sigilon Therapeutics initiated with a Buy at Jefferies
ADAP Adaptimmune
$5.58 /

-0.03 (-0.53%)

08/12/20 Piper Sandler
TCR2 Therapeutics initiated with an Overweight at Piper Sandler
06/01/20 Mizuho
Adaptimmune price target raised to $9 from $3 at Mizuho
05/29/20 JonesTrading
JonesTrading upgrades Adaptimmune to Buy after data alleviates 'key concern'
05/29/20 JonesTrading
Adaptimmune upgraded to Buy from Hold at JonesTrading
AGTC Applied Genetic
$4.95 /

-0.05 (-1.00%)

03/01/21 Stifel
Applied Genetic initiated with a Buy at Stifel
02/02/21 H.C. Wainwright
Applied Genetic price target raised to $24 from $18 at H.C. Wainwright
02/01/21 Roth Capital
Applied Genetic price target raised to $35 from $30 at Roth Capital
11/17/20 Roth Capital
Applied Genetic price target raised to $30 from $26 at Roth Capital
ATRA Atara Biotherapeutics
$14.68 /

+ (+0.00%)

03/25/21 Evercore ISI
Viracta Therapeutics initiated with an Outperform at Evercore ISI
03/02/21 Citi
Atara Biotherapeutics upgraded to Buy at Citi following 35% pullback
03/02/21 Citi
Atara Biotherapeutics upgraded to Buy from Neutral at Citi
01/04/21 Roth Capital
Roth keeps Buy rating on Atara Biotherapeutics after filing delay
CABA Cabaletta Bio
$11.61 /

+ (+0.00%)

03/17/21 H.C. Wainwright
Cabaletta Bio price target raised to $22 from $20 at H.C. Wainwright
01/08/21 Chardan
Cabaletta Bio initiated with a Buy at Chardan
10/13/20 H.C. Wainwright
Cabaletta Bio initiated with a Buy at H.C. Wainwright
FLXN Flexion
$8.65 /

-0.17 (-1.93%)

08/20/20 Goldman Sachs
Flexion initiated with a Neutral at Goldman Sachs
07/30/20 Oppenheimer
Flexion initiated with an Outperform at Oppenheimer
07/29/20
Fly Intel: Top five analyst initiations
07/29/20 Credit Suisse
Flexion initiated with an Outperform at Credit Suisse
DTIL Precision BioSciences
$10.30 /

-0.17 (-1.62%)

02/24/21
Fly Intel: Top five analyst initiations
02/24/21 JonesTrading
Precision BioSciences initiated with a Buy at JonesTrading
01/29/21 JPMorgan
Precision BioSciences price target raised to $14 from $10 at JPMorgan
12/15/20 H.C. Wainwright
Precision BioSciences transferred with Buy rating at H.C. Wainwright
DOV Dover
$140.45 /

+0.27 (+0.19%)

04/06/21 Barclays
Dover price target raised to $155 from $145 at Barclays
01/28/21 Baird
Dover price target raised to $147 from $140 at Baird
01/28/21 Baird
Dover results a solid beat with guidance above consensus, says Baird
01/05/21 Barclays
Dover price target raised to $141 from $138 at Barclays
GNPX Genprex
$4.14 /

-0.09 (-2.13%)

01/26/21 National Securities
Genprex initiated with a Buy at National Securities
04/22/20 Alliance Global Partners
Genprex initiated with a Buy at Alliance Global Partners
DBTX Decibel Therapeutics
$11.36 /

-0.03 (-0.26%)

03/09/21 Citi
Decibel Therapeutics initiated with a Buy at Citi
03/09/21 SVB Leerink
Decibel Therapeutics initiated with an Outperform at SVB Leerink
03/09/21 Barclays
Decibel Therapeutics initiated with an Overweight at Barclays
03/09/21 BMO Capital
Decibel Therapeutics initiated with an Outperform at BMO Capital
CYRX Cryoport
$50.71 /

+0.34 (+0.68%)

03/15/21
Fly Intel: Top five analyst initiations
03/15/21 UBS
Cryoport initiated with a Buy at UBS
03/02/21
Fly Intel: Top five analyst initiations
03/02/21 Needham
Cryoport assumed with a Buy at Needham
GLW Corning
$45.30 /

-0.19 (-0.42%)

01/28/21 Oppenheimer
Corning upgraded to Outperform from Perform at Oppenheimer
01/14/21 Barclays
Corning upgraded to Overweight with $44 target at Barclays
01/14/21 Barclays
Corning upgraded to Overweight from Equal Weight at Barclays
01/06/21
Fly Intel: Top five analyst initiations
FTV Fortive
$72.04 /

+0.08 (+0.11%)

04/06/21 Barclays
Fortive price target raised to $73 from $72 at Barclays
02/17/21
Fly Intel: Top five analyst downgrades
02/17/21 Morgan Stanley
Fortive downgraded to Equal Weight at Morgan Stanley after re-rating
02/17/21 Morgan Stanley
Fortive downgraded to Equal Weight from Overweight at Morgan Stanley
KRYS Krystal Biotech
$78.76 /

+0.03 (+0.04%)

03/01/21 H.C. Wainwright
Krystal Biotech price target raised to $103 from $84 at H.C. Wainwright
03/01/21 William Blair
Krystal Biotech has 'catalyst-rich year ahead,' says William Blair
02/09/21 JonesTrading
Krystal Biotech initiated with a Buy at JonesTrading
01/15/21 Chardan
Krystal Biotech named a 'Top Pick for 2021' at Chardan
NVO Novo Nordisk
$68.09 /

-0.19 (-0.28%)

02/11/21 UBS
Novo Nordisk price target raised to DKK 425 from DKK 415 at UBS
02/04/21 Barclays
Novo Nordisk price target raised to DKK 495 from DKK 485 at Barclays
01/20/21 Citi
Citi opens 'Positive Catalyst Watch' on Novo Nordisk
01/20/21 Credit Suisse
Novo Nordisk downgraded to Neutral from Outperform at Credit Suisse
NVS Novartis
$87.06 /

-0.23 (-0.26%)

04/05/21 Morgan Stanley
Regenxbio AAV9 patent challenged by Passage Bio, says Morgan Stanley
03/23/21 Societe Generale
Novartis price target raised to CHF 107 from CHF 104 at Societe Generale
03/22/21 Bernstein
Novartis initiated with a Market Perform at Bernstein
03/10/21
Fly Intel: Top five analyst downgrades
ORTX Orchard Therapeutics
$7.19 /

-0.04 (-0.55%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/02/21 JPMorgan
Orchard Therapeutics assumed with an Overweight at JPMorgan
03/01/21 Stifel
Orchard Therapeutics initiated with a Buy at Stifel
02/18/21 Goldman Sachs
Orchard selloff on Bluebird Bio news overdone, says Goldman Sachs
MRK Merck
$76.44 /

-0.56 (-0.73%)

04/01/21 Morgan Stanley
Merck cancer pipeline underappreciated and 'set to flow,' says Morgan Stanley
03/15/21 Piper Sandler
Gilead pact with Merck can bring HIV sustainability, says Piper Sandler
02/25/21 SVB Leerink
Pandion Therapeutics downgraded to Market Perform from Outperform at SVB Leerink
MEDP Medpace
$173.03 /

+2.1 (+1.23%)

02/17/21 Truist
Medpace price target raised to $180 from $135 at Truist
02/16/21 Credit Suisse
Medpace price target raised to $178 from $155 at Credit Suisse
10/02/20 Truist
Medpace upgraded to Buy from Hold at Truist
07/29/20 Truist
Medpace price target raised to $124 from $95 at SunTrust
IOVA Iovance Biotherapeutics
$31.80 /

-0.35 (-1.09%)

03/08/21 H.C. Wainwright
Iovance Biotherapeutics upgraded to Buy from Neutral at H.C. Wainwright
01/29/21 Baird
Iovance Biotherapeutics assumed at Outperform at Baird
01/14/21 Oppenheimer
Iovance Biotherapeutics price target raised to $57 from $43 at Oppenheimer
12/17/20 Barclays
Iovance Biotherapeutics price target raised to $55 from $43 at Barclays
FOLD Amicus
$9.89 /

-0.055 (-0.55%)

03/01/21 Stifel
Amicus initiated with a Hold at Stifel
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 JPMorgan
Amicus downgraded to Neutral on Pompe disease miss at JPMorgan
02/12/21 SVB Leerink
Amicus downgraded to Market Perform from Outperform at SVB Leerink
TMO Thermo Fisher
$465.69 /

+0.13 (+0.03%)

SGTX Sigilon Therapeutics
$20.04 /

+0.02 (+0.10%)

ORTX Orchard Therapeutics
$7.19 /

-0.04 (-0.55%)

NVS Novartis
$87.06 /

-0.23 (-0.26%)

NVO Novo Nordisk
$68.09 /

-0.19 (-0.28%)

MRK Merck
$76.44 /

-0.56 (-0.73%)

MEDP Medpace
$173.03 /

+2.1 (+1.23%)

KRYS Krystal Biotech
$78.76 /

+0.03 (+0.04%)

IOVA Iovance Biotherapeutics
$31.80 /

-0.35 (-1.09%)

GLW Corning
$45.30 /

-0.19 (-0.42%)

GILD Gilead
$66.10 /

-0.25 (-0.38%)

FTV Fortive
$72.04 /

+0.08 (+0.11%)

FOLD Amicus
$9.89 /

-0.055 (-0.55%)

FLXN Flexion
$8.65 /

-0.17 (-1.93%)

DTIL Precision BioSciences
$10.30 /

-0.17 (-1.62%)

DOV Dover
$140.45 /

+0.27 (+0.19%)

CYRX Cryoport
$50.71 /

+0.34 (+0.68%)

CABA Cabaletta Bio
$11.61 /

+ (+0.00%)

BLUE Bluebird Bio
$30.45 /

-0.65 (-2.09%)

ATRA Atara Biotherapeutics
$14.68 /

+ (+0.00%)

AGTC Applied Genetic
$4.95 /

-0.05 (-1.00%)

ADAP Adaptimmune
$5.58 /

-0.03 (-0.53%)

  • 12
    Feb
  • 03
    Feb
  • 28
    Jan
  • 21
    Jan
  • 09
    Dec
  • 04
    Dec
  • 02
    Jun
  • 29
    May
  • 27
    May
  • 21
    May
  • 19
    May
  • 19
    May
TMO Thermo Fisher
$465.69 /

+0.13 (+0.03%)

NVS Novartis
$87.06 /

-0.23 (-0.26%)

MRK Merck
$76.44 /

-0.56 (-0.73%)

GLW Corning
$45.30 /

-0.19 (-0.42%)

GILD Gilead
$66.10 /

-0.25 (-0.38%)

FTV Fortive
$72.04 /

+0.08 (+0.11%)

FOLD Amicus
$9.89 /

-0.055 (-0.55%)

CYRX Cryoport
$50.71 /

+0.34 (+0.68%)

BLUE Bluebird Bio
$30.45 /

-0.65 (-2.09%)

TMO Thermo Fisher
$465.69 /

+0.13 (+0.03%)

SGTX Sigilon Therapeutics
$20.04 /

+0.02 (+0.10%)

NVS Novartis
$87.06 /

-0.23 (-0.26%)

MRK Merck
$76.44 /

-0.56 (-0.73%)

IOVA Iovance Biotherapeutics
$31.80 /

-0.35 (-1.09%)

GLW Corning
$45.30 /

-0.19 (-0.42%)

GILD Gilead
$66.10 /

-0.25 (-0.38%)

FOLD Amicus
$9.89 /

-0.055 (-0.55%)

DTIL Precision BioSciences
$10.30 /

-0.17 (-1.62%)

DOV Dover
$140.45 /

+0.27 (+0.19%)

DBTX Decibel Therapeutics
$11.36 /

-0.03 (-0.26%)

BLUE Bluebird Bio
$30.45 /

-0.65 (-2.09%)

ATRA Atara Biotherapeutics
$14.68 /

+ (+0.00%)

AGTC Applied Genetic
$4.95 /

-0.05 (-1.00%)

NVO Novo Nordisk
$68.09 /

-0.19 (-0.28%)

MRK Merck
$76.44 /

-0.56 (-0.73%)

IOVA Iovance Biotherapeutics
$31.80 /

-0.35 (-1.09%)

GLW Corning
$45.30 /

-0.19 (-0.42%)

GILD Gilead
$66.10 /

-0.25 (-0.38%)

FOLD Amicus
$9.89 /

-0.055 (-0.55%)

CABA Cabaletta Bio
$11.61 /

+ (+0.00%)

BLUE Bluebird Bio
$30.45 /

-0.65 (-2.09%)

Over a week ago
Conference/Events
Hanson Wade to hold a virtual conference » 04:55
04/01/21
04/01
04:55
04/01/21
04:55
BIIB

Biogen

$280.05 /

+4.17 (+1.51%)

, PFE

Pfizer

$36.24 /

+0.13 (+0.36%)

, RARE

Ultragenyx

$114.03 /

+2.24 (+2.00%)

, FOLD

Amicus

$9.89 /

+0.49 (+5.21%)

, ORTX

Orchard Therapeutics

$7.23 /

+0.07 (+0.98%)

, QGEN

Qiagen

$48.73 /

+0.765 (+1.60%)

Gene Therapy…

Gene Therapy Comparabililty Virtual Conference will be held on March 31-April 1.

ShowHide Related Items >><<
RARE Ultragenyx
$114.03 /

+2.24 (+2.00%)

QGEN Qiagen
$48.73 /

+0.765 (+1.60%)

PFE Pfizer
$36.24 /

+0.13 (+0.36%)

ORTX Orchard Therapeutics
$7.23 /

+0.07 (+0.98%)

FOLD Amicus
$9.89 /

+0.49 (+5.21%)

BIIB Biogen
$280.05 /

+4.17 (+1.51%)

BIIB Biogen
$280.05 /

+4.17 (+1.51%)

03/25/21 Piper Sandler
Piper says Biogen Tecfidera patents could change thesis, but sees unknowns
03/25/21 Mizuho
Two 'low probability' Biogen events could drive upside, says Mizuho
03/23/21 Piper Sandler
Neurologist survey shows erosion for Biogen franchises, says Piper Sandler
02/17/21 Cantor Fitzgerald
Biogen price target lowered to $268 from $278 at Cantor Fitzgerald
PFE Pfizer
$36.24 /

+0.13 (+0.36%)

03/17/21 Mizuho
AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/10/21 KeyBanc
Maravai Lifesciences price target raised to $39 from $33 at KeyBanc
02/04/21 DZ Bank
Pfizer upgraded to Buy from Hold at DZ Bank
RARE Ultragenyx
$114.03 /

+2.24 (+2.00%)

03/24/21 Stifel
Stifel remains optimistic on GTX-102 and Ultragenyx ahead of 'important' update
03/01/21 Stifel
Ultragenyx resumed with a Buy at Stifel
02/12/21 Wedbush
Ultragenyx price target raised to $130 from $113 at Wedbush
02/12/21 Barclays
Ultragenyx price target raised to $186 from $176 at Barclays
FOLD Amicus
$9.89 /

+0.49 (+5.21%)

03/01/21 Stifel
Amicus initiated with a Hold at Stifel
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 JPMorgan
Amicus downgraded to Neutral on Pompe disease miss at JPMorgan
02/12/21 SVB Leerink
Amicus downgraded to Market Perform from Outperform at SVB Leerink
ORTX Orchard Therapeutics
$7.23 /

+0.07 (+0.98%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/02/21 JPMorgan
Orchard Therapeutics assumed with an Overweight at JPMorgan
03/01/21 Stifel
Orchard Therapeutics initiated with a Buy at Stifel
02/18/21 Goldman Sachs
Orchard selloff on Bluebird Bio news overdone, says Goldman Sachs
QGEN Qiagen
$48.73 /

+0.765 (+1.60%)

02/19/21 Berenberg
Qiagen price target raised to EUR 56 from EUR 52 at Berenberg
02/09/21 William Blair
Quidel, Qiagen merger would not make sense, says William Blair
02/09/21 Wells Fargo
Qiagen shares should be sold on latest merger talk, says Wells Fargo
02/09/21 Citi
Merger with Qiagen would benefit Quidel, says Citi
RARE Ultragenyx
$114.03 /

+2.24 (+2.00%)

QGEN Qiagen
$48.73 /

+0.765 (+1.60%)

PFE Pfizer
$36.24 /

+0.13 (+0.36%)

ORTX Orchard Therapeutics
$7.23 /

+0.07 (+0.98%)

FOLD Amicus
$9.89 /

+0.49 (+5.21%)

BIIB Biogen
$280.05 /

+4.17 (+1.51%)

  • 29
    Oct
QGEN Qiagen
$48.73 /

+0.765 (+1.60%)

PFE Pfizer
$36.24 /

+0.13 (+0.36%)

FOLD Amicus
$9.89 /

+0.49 (+5.21%)

BIIB Biogen
$280.05 /

+4.17 (+1.51%)

QGEN Qiagen
$48.73 /

+0.765 (+1.60%)

PFE Pfizer
$36.24 /

+0.13 (+0.36%)

FOLD Amicus
$9.89 /

+0.49 (+5.21%)

BIIB Biogen
$280.05 /

+4.17 (+1.51%)

QGEN Qiagen
$48.73 /

+0.765 (+1.60%)

PFE Pfizer
$36.24 /

+0.13 (+0.36%)

FOLD Amicus
$9.89 /

+0.49 (+5.21%)

BIIB Biogen
$280.05 /

+4.17 (+1.51%)

Conference/Events
Hanson Wade to hold a virtual conference » 10:37
03/31/21
03/31
10:37
03/31/21
10:37
BIIB

Biogen

$277.54 /

+1.66 (+0.60%)

, PFE

Pfizer

$36.18 /

+0.065 (+0.18%)

, RARE

Ultragenyx

$114.14 /

+2.35 (+2.10%)

, FOLD

Amicus

$9.68 /

+0.28 (+2.98%)

, ORTX

Orchard Therapeutics

$7.24 /

+0.08 (+1.12%)

, QGEN

Qiagen

$48.43 /

+0.47 (+0.98%)

Gene Therapy…

Gene Therapy Comparabililty Virtual Conference will be held on March 31-April 1.

ShowHide Related Items >><<
RARE Ultragenyx
$114.14 /

+2.35 (+2.10%)

QGEN Qiagen
$48.43 /

+0.47 (+0.98%)

PFE Pfizer
$36.18 /

+0.065 (+0.18%)

ORTX Orchard Therapeutics
$7.24 /

+0.08 (+1.12%)

FOLD Amicus
$9.68 /

+0.28 (+2.98%)

BIIB Biogen
$277.54 /

+1.66 (+0.60%)

BIIB Biogen
$277.54 /

+1.66 (+0.60%)

03/25/21 Piper Sandler
Piper says Biogen Tecfidera patents could change thesis, but sees unknowns
03/25/21 Mizuho
Two 'low probability' Biogen events could drive upside, says Mizuho
03/23/21 Piper Sandler
Neurologist survey shows erosion for Biogen franchises, says Piper Sandler
02/17/21 Cantor Fitzgerald
Biogen price target lowered to $268 from $278 at Cantor Fitzgerald
PFE Pfizer
$36.18 /

+0.065 (+0.18%)

03/17/21 Mizuho
AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/10/21 KeyBanc
Maravai Lifesciences price target raised to $39 from $33 at KeyBanc
02/04/21 DZ Bank
Pfizer upgraded to Buy from Hold at DZ Bank
RARE Ultragenyx
$114.14 /

+2.35 (+2.10%)

03/24/21 Stifel
Stifel remains optimistic on GTX-102 and Ultragenyx ahead of 'important' update
03/01/21 Stifel
Ultragenyx resumed with a Buy at Stifel
02/12/21 Wedbush
Ultragenyx price target raised to $130 from $113 at Wedbush
02/12/21 Barclays
Ultragenyx price target raised to $186 from $176 at Barclays
FOLD Amicus
$9.68 /

+0.28 (+2.98%)

03/01/21 Stifel
Amicus initiated with a Hold at Stifel
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 JPMorgan
Amicus downgraded to Neutral on Pompe disease miss at JPMorgan
02/12/21 SVB Leerink
Amicus downgraded to Market Perform from Outperform at SVB Leerink
ORTX Orchard Therapeutics
$7.24 /

+0.08 (+1.12%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/02/21 JPMorgan
Orchard Therapeutics assumed with an Overweight at JPMorgan
03/01/21 Stifel
Orchard Therapeutics initiated with a Buy at Stifel
02/18/21 Goldman Sachs
Orchard selloff on Bluebird Bio news overdone, says Goldman Sachs
QGEN Qiagen
$48.43 /

+0.47 (+0.98%)

02/19/21 Berenberg
Qiagen price target raised to EUR 56 from EUR 52 at Berenberg
02/09/21 William Blair
Quidel, Qiagen merger would not make sense, says William Blair
02/09/21 Wells Fargo
Qiagen shares should be sold on latest merger talk, says Wells Fargo
02/09/21 Citi
Merger with Qiagen would benefit Quidel, says Citi
RARE Ultragenyx
$114.14 /

+2.35 (+2.10%)

QGEN Qiagen
$48.43 /

+0.47 (+0.98%)

PFE Pfizer
$36.18 /

+0.065 (+0.18%)

ORTX Orchard Therapeutics
$7.24 /

+0.08 (+1.12%)

FOLD Amicus
$9.68 /

+0.28 (+2.98%)

BIIB Biogen
$277.54 /

+1.66 (+0.60%)

  • 29
    Oct
QGEN Qiagen
$48.43 /

+0.47 (+0.98%)

PFE Pfizer
$36.18 /

+0.065 (+0.18%)

FOLD Amicus
$9.68 /

+0.28 (+2.98%)

BIIB Biogen
$277.54 /

+1.66 (+0.60%)

QGEN Qiagen
$48.43 /

+0.47 (+0.98%)

PFE Pfizer
$36.18 /

+0.065 (+0.18%)

FOLD Amicus
$9.68 /

+0.28 (+2.98%)

BIIB Biogen
$277.54 /

+1.66 (+0.60%)

QGEN Qiagen
$48.43 /

+0.47 (+0.98%)

PFE Pfizer
$36.18 /

+0.065 (+0.18%)

FOLD Amicus
$9.68 /

+0.28 (+2.98%)

BIIB Biogen
$277.54 /

+1.66 (+0.60%)

Conference/Events
Muscular Dystrophy Association to hold a virtual conference » 04:55
03/18/21
03/18
04:55
03/18/21
04:55
ALXN

Alexion

$153.23 /

-0.09 (-0.06%)

, BHVN

Biohaven Pharmaceutical

$77.11 /

+1.39 (+1.84%)

, BIIB

Biogen

$264.14 /

+4.36 (+1.68%)

, CPRX

Catalyst Pharmaceuticals

$4.22 /

+0.1 (+2.43%)

, CYTK

Cytokinetics

$25.69 /

+1.87 (+7.85%)

, DYN

Dyne Therapeutics

$16.58 /

-0.055 (-0.33%)

, FOLD

Amicus

$10.55 /

+0.06 (+0.57%)

, NVS

Novartis

$85.74 /

-0.23 (-0.27%)

, ORPH

Orphazyme

$12.75 /

-0.55 (-4.14%)

, PKI

PerkinElmer

$126.38 /

+0.4 (+0.32%)

, PTCT

PTC Therapeutics

$55.75 /

-1.98 (-3.43%)

, REGN

Regeneron

$496.30 /

+14.06 (+2.92%)

, SLDB

Solid Biosciences

$6.67 /

+0.22 (+3.41%)

, SNY

Sanofi

$49.06 /

-0.33 (-0.67%)

, SRPT

Sarepta

$84.92 /

+0.505 (+0.60%)

MDA Clinical &…

MDA Clinical & Scientific Virtual Conference 2021 will be held on March 14-18. Webcast Link

ShowHide Related Items >><<
SRPT Sarepta
$84.92 /

+0.505 (+0.60%)

SNY Sanofi
$49.06 /

-0.33 (-0.67%)

SLDB Solid Biosciences
$6.67 /

+0.22 (+3.41%)

REGN Regeneron
$496.30 /

+14.06 (+2.92%)

PTCT PTC Therapeutics
$55.75 /

-1.98 (-3.43%)

PKI PerkinElmer
$126.38 /

+0.4 (+0.32%)

ORPH Orphazyme
$12.75 /

-0.55 (-4.14%)

NVS Novartis
$85.74 /

-0.23 (-0.27%)

FOLD Amicus
$10.55 /

+0.06 (+0.57%)

DYN Dyne Therapeutics
$16.58 /

-0.055 (-0.33%)

CYTK Cytokinetics
$25.69 /

+1.87 (+7.85%)

CPRX Catalyst Pharmaceuticals
$4.22 /

+0.1 (+2.43%)

BIIB Biogen
$264.14 /

+4.36 (+1.68%)

BHVN Biohaven Pharmaceutical
$77.11 /

+1.39 (+1.84%)

ALXN Alexion
$153.23 /

-0.09 (-0.06%)

ALXN Alexion
$153.23 /

-0.09 (-0.06%)

02/04/21 Piper Sandler
Alexion downgraded to Neutral ahead of expected deal closing at Piper Sandler
02/04/21 Piper Sandler
Alexion downgraded to Neutral from Overweight at Piper Sandler
01/08/21 Raymond James
Alexion downgraded to Market Perform from Outperform at Raymond James
12/16/20 Truist
Alexion downgraded to Hold from Buy at Truist
BHVN Biohaven Pharmaceutical
$77.11 /

+1.39 (+1.84%)

03/11/21
Fly Intel: Top five analyst initiations
03/11/21 UBS
Biohaven Pharmaceutical initiated with a Buy at UBS
03/02/21 Mizuho
Biohaven Pharmaceutical price target raised to $103 from $93 at Mizuho
03/01/21 Piper Sandler
Biohaven price target raised to $110 from $90 at Piper Sandler
BIIB Biogen
$264.14 /

+4.36 (+1.68%)

02/17/21 Cantor Fitzgerald
Biogen price target lowered to $268 from $278 at Cantor Fitzgerald
02/08/21 Citi
Expert sees Biogen aducanumab approval 50/50 at best, says Citi
02/04/21 SVB Leerink
Biogen price target lowered to $380 from $430 at SVB Leerink
02/04/21 Credit Suisse
Biogen price target lowered to $338 from $350 at Credit Suisse
CPRX Catalyst Pharmaceuticals
$4.22 /

+0.1 (+2.43%)

03/16/21 Piper Sandler
Catalyst business continues to generate cash flow, says Piper Sandler
01/07/21 Piper Sandler
Piper says Catalyst's Firdapse commercial business performing as expected
01/06/21 Piper Sandler
Catalyst Firdapse commercial business performing as expected, says Piper Sandler
11/10/20 Piper Sandler
Catalyst Pharmaceuticals price target lowered to $5.50 from $6 at Piper Sandler
CYTK Cytokinetics
$25.69 /

+1.87 (+7.85%)

03/11/21 Wolfe Research
Cytokinetics initiated with an Outperform at Wolfe Research
02/18/21 Barclays
Cytokinetics initiated with an Overweight at Barclays
01/20/21 H.C. Wainwright
Cytokinetics price target raised to $41 from $22 at H.C. Wainwright
12/28/20 Oppenheimer
Amgen price target lowered to $266 from $274 at Oppenheimer
DYN Dyne Therapeutics
$16.58 /

-0.055 (-0.33%)

03/05/21 Stifel
Dyne Therapeutics weakness a buying opportunity, says Stifel
02/09/21
Dyne Therapeutics initiated with a Buy at JonesTrading
01/07/21 Piper Sandler
Dyne Therapeutics potential beneficiary of Sarepta's SRP-9001 miss, says Piper
10/12/20 Jefferies
Dyne Therapeutics initiated with a Buy at Jefferies
FOLD Amicus
$10.55 /

+0.06 (+0.57%)

03/01/21 Stifel
Amicus initiated with a Hold at Stifel
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 JPMorgan
Amicus downgraded to Neutral on Pompe disease miss at JPMorgan
02/12/21 SVB Leerink
Amicus downgraded to Market Perform from Outperform at SVB Leerink
NVS Novartis
$85.74 /

-0.23 (-0.27%)

03/10/21
Fly Intel: Top five analyst downgrades
03/10/21 Argus
Novartis cut to Hold at Argus on slowing top-line growth, greater competition
03/10/21 Argus
Novartis downgraded to Hold from Buy at Argus
03/01/21 Oppenheimer
Homology Medicines loses potential source of upside, says Oppenheimer
ORPH Orphazyme
$12.75 /

-0.55 (-4.14%)

10/26/20 Guggenheim
Orphazyme initiated with a Buy at Guggenheim
10/26/20 BofA
Orphazyme initiated with a Buy at BofA
10/26/20 BofA
Orphazyme initiated with a Buy at BofA
PKI PerkinElmer
$126.38 /

+0.4 (+0.32%)

02/03/21 Citi
PerkinElmer price target raised to $155 from $150 at Citi
01/07/21 Piper Sandler
Oxford Immunotec downgraded to Neutral from Overweight at Piper Sandler
01/07/21 Wells Fargo
PerkinElmer upgraded to Overweight from Equal Weight at Wells Fargo
01/07/21 Wells Fargo
PerkinElmer upgraded to Overweight from Equal Weight at Wells Fargo
PTCT PTC Therapeutics
$55.75 /

-1.98 (-3.43%)

02/26/21 Cantor Fitzgerald
PTC Therapeutics price target lowered to $75 from $81 at Cantor Fitzgerald
02/12/21 BofA
PTC Therapeutics downgraded to Neutral from Buy at BofA
02/12/21 BofA
PTC Therapeutics downgraded to Neutral from Buy at BofA
01/05/21 Citi
PTC Therapeutics upgraded to Buy from Neutral at Citi
REGN Regeneron
$496.30 /

+14.06 (+2.92%)

03/11/21 Evercore ISI
Kodiak Sciences initiated with an Outperform at Evercore ISI
03/11/21 Needham
Vir Biotechnology price target raised to $80 from $75 at Needham
02/23/21 Credit Suisse
Regeneron price target raised to $760 from $753 at Credit Suisse
02/16/21 Cantor Fitzgerald
Regeneron price target lowered to $656 from $696 at Cantor Fitzgerald
SLDB Solid Biosciences
$6.67 /

+0.22 (+3.41%)

03/16/21 Chardan
Solid Biosciences price target raised to $20 from $12.50 at Chardan
03/16/21
Fly Intel: Top five analyst upgrades
03/16/21 SVB Leerink
Solid Biosciences upgraded to Outperform at SVB Leerink
03/16/21 SVB Leerink
Solid Biosciences upgraded to Outperform from Market Perform at SVB Leerink
SNY Sanofi
$49.06 /

-0.33 (-0.67%)

02/23/21 BofA
BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list
02/10/21 Morgan Stanley
Sanofi price target raised to EUR 104 from EUR 101 at Morgan Stanley
02/05/21 Piper Sandler
Piper reiterates Overweight on Kymera after Sanofi capital markets day
01/19/21 UBS
Sanofi price target lowered to EUR 99 from EUR 100 at UBS
SRPT Sarepta
$84.92 /

+0.505 (+0.60%)

03/02/21 RBC Capital
Sarepta price target lowered to $132 from $143 at RBC Capital
03/02/21 Piper Sandler
Sarepta price target lowered to $130 from $140 at Piper Sandler
02/26/21 Mizuho
Sarepta price target raised to $160 from $158 at Mizuho
02/25/21 Piper Sandler
Piper says Sarepta's Amondys 45 approval comes with 'relatively clean label'
SRPT Sarepta
$84.92 /

+0.505 (+0.60%)

SNY Sanofi
$49.06 /

-0.33 (-0.67%)

SLDB Solid Biosciences
$6.67 /

+0.22 (+3.41%)

REGN Regeneron
$496.30 /

+14.06 (+2.92%)

PTCT PTC Therapeutics
$55.75 /

-1.98 (-3.43%)

PKI PerkinElmer
$126.38 /

+0.4 (+0.32%)

NVS Novartis
$85.74 /

-0.23 (-0.27%)

FOLD Amicus
$10.55 /

+0.06 (+0.57%)

DYN Dyne Therapeutics
$16.58 /

-0.055 (-0.33%)

CYTK Cytokinetics
$25.69 /

+1.87 (+7.85%)

CPRX Catalyst Pharmaceuticals
$4.22 /

+0.1 (+2.43%)

BIIB Biogen
$264.14 /

+4.36 (+1.68%)

BHVN Biohaven Pharmaceutical
$77.11 /

+1.39 (+1.84%)

ALXN Alexion
$153.23 /

-0.09 (-0.06%)

  • 19
    Mar
  • 16
    Mar
  • 21
    Jan
  • 29
    Sep
  • 17
    Sep
  • 17
    Jul
  • 27
    May
SNY Sanofi
$49.06 /

-0.33 (-0.67%)

REGN Regeneron
$496.30 /

+14.06 (+2.92%)

NVS Novartis
$85.74 /

-0.23 (-0.27%)

FOLD Amicus
$10.55 /

+0.06 (+0.57%)

BIIB Biogen
$264.14 /

+4.36 (+1.68%)

ALXN Alexion
$153.23 /

-0.09 (-0.06%)

SRPT Sarepta
$84.92 /

+0.505 (+0.60%)

SNY Sanofi
$49.06 /

-0.33 (-0.67%)

SLDB Solid Biosciences
$6.67 /

+0.22 (+3.41%)

REGN Regeneron
$496.30 /

+14.06 (+2.92%)

PTCT PTC Therapeutics
$55.75 /

-1.98 (-3.43%)

PKI PerkinElmer
$126.38 /

+0.4 (+0.32%)

ORPH Orphazyme
$12.75 /

-0.55 (-4.14%)

NVS Novartis
$85.74 /

-0.23 (-0.27%)

FOLD Amicus
$10.55 /

+0.06 (+0.57%)

DYN Dyne Therapeutics
$16.58 /

-0.055 (-0.33%)

CYTK Cytokinetics
$25.69 /

+1.87 (+7.85%)

CPRX Catalyst Pharmaceuticals
$4.22 /

+0.1 (+2.43%)

BIIB Biogen
$264.14 /

+4.36 (+1.68%)

ALXN Alexion
$153.23 /

-0.09 (-0.06%)

REGN Regeneron
$496.30 /

+14.06 (+2.92%)

FOLD Amicus
$10.55 /

+0.06 (+0.57%)

CYTK Cytokinetics
$25.69 /

+1.87 (+7.85%)

BIIB Biogen
$264.14 /

+4.36 (+1.68%)

ALXN Alexion
$153.23 /

-0.09 (-0.06%)

Conference/Events
Muscular Dystrophy Association to hold a virtual conference » 04:55
03/18/21
03/18
04:55
03/18/21
04:55
ALXN

Alexion

$153.23 /

-0.09 (-0.06%)

, SDNA

Sedona Corporation

$0.00 /

+ (+0.00%)

, BIIB

Biogen

$264.14 /

+4.36 (+1.68%)

, PTCT

PTC Therapeutics

$55.75 /

-1.98 (-3.43%)

, SRPT

Sarepta

$84.92 /

+0.505 (+0.60%)

, NVS

Novartis

$85.74 /

-0.23 (-0.27%)

, SNY

Sanofi

$49.06 /

-0.33 (-0.67%)

, SLDB

Solid Biosciences

$6.67 /

+0.22 (+3.41%)

, REGN

Regeneron

$496.30 /

+14.06 (+2.92%)

, BHVN

Biohaven Pharmaceutical

$77.11 /

+1.39 (+1.84%)

, ORPH

Orphazyme

$12.75 /

-0.55 (-4.14%)

, CPRX

Catalyst Pharmaceuticals

$4.22 /

+0.1 (+2.43%)

, DYN

Dyne Therapeutics

$16.58 /

-0.055 (-0.33%)

, CYTK

Cytokinetics

$25.69 /

+1.87 (+7.85%)

, FOLD

Amicus

$10.55 /

+0.06 (+0.57%)

, PKI

PerkinElmer

$126.38 /

+0.4 (+0.32%)

MDA Clinical &…

MDA Clinical & Scientific Virtual Conference 2021 will be held on March 14-18. Webcast Link

ShowHide Related Items >><<
SRPT Sarepta
$84.92 /

+0.505 (+0.60%)

SNY Sanofi
$49.06 /

-0.33 (-0.67%)

SLDB Solid Biosciences
$6.67 /

+0.22 (+3.41%)

REGN Regeneron
$496.30 /

+14.06 (+2.92%)

PTCT PTC Therapeutics
$55.75 /

-1.98 (-3.43%)

PKI PerkinElmer
$126.38 /

+0.4 (+0.32%)

ORPH Orphazyme
$12.75 /

-0.55 (-4.14%)

NVS Novartis
$85.74 /

-0.23 (-0.27%)

FOLD Amicus
$10.55 /

+0.06 (+0.57%)

DYN Dyne Therapeutics
$16.58 /

-0.055 (-0.33%)

CYTK Cytokinetics
$25.69 /

+1.87 (+7.85%)

CPRX Catalyst Pharmaceuticals
$4.22 /

+0.1 (+2.43%)

BIIB Biogen
$264.14 /

+4.36 (+1.68%)

BHVN Biohaven Pharmaceutical
$77.11 /

+1.39 (+1.84%)

ALXN Alexion
$153.23 /

-0.09 (-0.06%)

ALXN Alexion
$153.23 /

-0.09 (-0.06%)

02/04/21 Piper Sandler
Alexion downgraded to Neutral ahead of expected deal closing at Piper Sandler
02/04/21 Piper Sandler
Alexion downgraded to Neutral from Overweight at Piper Sandler
01/08/21 Raymond James
Alexion downgraded to Market Perform from Outperform at Raymond James
12/16/20 Truist
Alexion downgraded to Hold from Buy at Truist
SDNA Sedona Corporation
$0.00 /

+ (+0.00%)

BIIB Biogen
$264.14 /

+4.36 (+1.68%)

02/17/21 Cantor Fitzgerald
Biogen price target lowered to $268 from $278 at Cantor Fitzgerald
02/08/21 Citi
Expert sees Biogen aducanumab approval 50/50 at best, says Citi
02/04/21 SVB Leerink
Biogen price target lowered to $380 from $430 at SVB Leerink
02/04/21 Credit Suisse
Biogen price target lowered to $338 from $350 at Credit Suisse
PTCT PTC Therapeutics
$55.75 /

-1.98 (-3.43%)

02/26/21 Cantor Fitzgerald
PTC Therapeutics price target lowered to $75 from $81 at Cantor Fitzgerald
02/12/21 BofA
PTC Therapeutics downgraded to Neutral from Buy at BofA
02/12/21 BofA
PTC Therapeutics downgraded to Neutral from Buy at BofA
01/05/21 Citi
PTC Therapeutics upgraded to Buy from Neutral at Citi
SRPT Sarepta
$84.92 /

+0.505 (+0.60%)

03/02/21 RBC Capital
Sarepta price target lowered to $132 from $143 at RBC Capital
03/02/21 Piper Sandler
Sarepta price target lowered to $130 from $140 at Piper Sandler
02/26/21 Mizuho
Sarepta price target raised to $160 from $158 at Mizuho
02/25/21 Piper Sandler
Piper says Sarepta's Amondys 45 approval comes with 'relatively clean label'
NVS Novartis
$85.74 /

-0.23 (-0.27%)

03/10/21
Fly Intel: Top five analyst downgrades
03/10/21 Argus
Novartis cut to Hold at Argus on slowing top-line growth, greater competition
03/10/21 Argus
Novartis downgraded to Hold from Buy at Argus
03/01/21 Oppenheimer
Homology Medicines loses potential source of upside, says Oppenheimer
SNY Sanofi
$49.06 /

-0.33 (-0.67%)

02/23/21 BofA
BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list
02/10/21 Morgan Stanley
Sanofi price target raised to EUR 104 from EUR 101 at Morgan Stanley
02/05/21 Piper Sandler
Piper reiterates Overweight on Kymera after Sanofi capital markets day
01/19/21 UBS
Sanofi price target lowered to EUR 99 from EUR 100 at UBS
SLDB Solid Biosciences
$6.67 /

+0.22 (+3.41%)

03/16/21 Chardan
Solid Biosciences price target raised to $20 from $12.50 at Chardan
03/16/21
Fly Intel: Top five analyst upgrades
03/16/21 SVB Leerink
Solid Biosciences upgraded to Outperform at SVB Leerink
03/16/21 SVB Leerink
Solid Biosciences upgraded to Outperform from Market Perform at SVB Leerink
REGN Regeneron
$496.30 /

+14.06 (+2.92%)

03/11/21 Evercore ISI
Kodiak Sciences initiated with an Outperform at Evercore ISI
03/11/21 Needham
Vir Biotechnology price target raised to $80 from $75 at Needham
02/23/21 Credit Suisse
Regeneron price target raised to $760 from $753 at Credit Suisse
02/16/21 Cantor Fitzgerald
Regeneron price target lowered to $656 from $696 at Cantor Fitzgerald
BHVN Biohaven Pharmaceutical
$77.11 /

+1.39 (+1.84%)

03/11/21
Fly Intel: Top five analyst initiations
03/11/21 UBS
Biohaven Pharmaceutical initiated with a Buy at UBS
03/02/21 Mizuho
Biohaven Pharmaceutical price target raised to $103 from $93 at Mizuho
03/01/21 Piper Sandler
Biohaven price target raised to $110 from $90 at Piper Sandler
ORPH Orphazyme
$12.75 /

-0.55 (-4.14%)

10/26/20 Guggenheim
Orphazyme initiated with a Buy at Guggenheim
10/26/20 BofA
Orphazyme initiated with a Buy at BofA
10/26/20 BofA
Orphazyme initiated with a Buy at BofA
CPRX Catalyst Pharmaceuticals
$4.22 /

+0.1 (+2.43%)

03/16/21 Piper Sandler
Catalyst business continues to generate cash flow, says Piper Sandler
01/07/21 Piper Sandler
Piper says Catalyst's Firdapse commercial business performing as expected
01/06/21 Piper Sandler
Catalyst Firdapse commercial business performing as expected, says Piper Sandler
11/10/20 Piper Sandler
Catalyst Pharmaceuticals price target lowered to $5.50 from $6 at Piper Sandler
DYN Dyne Therapeutics
$16.58 /

-0.055 (-0.33%)

03/05/21 Stifel
Dyne Therapeutics weakness a buying opportunity, says Stifel
02/09/21
Dyne Therapeutics initiated with a Buy at JonesTrading
01/07/21 Piper Sandler
Dyne Therapeutics potential beneficiary of Sarepta's SRP-9001 miss, says Piper
10/12/20 Jefferies
Dyne Therapeutics initiated with a Buy at Jefferies
CYTK Cytokinetics
$25.69 /

+1.87 (+7.85%)

03/11/21 Wolfe Research
Cytokinetics initiated with an Outperform at Wolfe Research
02/18/21 Barclays
Cytokinetics initiated with an Overweight at Barclays
01/20/21 H.C. Wainwright
Cytokinetics price target raised to $41 from $22 at H.C. Wainwright
12/28/20 Oppenheimer
Amgen price target lowered to $266 from $274 at Oppenheimer
FOLD Amicus
$10.55 /

+0.06 (+0.57%)

03/01/21 Stifel
Amicus initiated with a Hold at Stifel
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 JPMorgan
Amicus downgraded to Neutral on Pompe disease miss at JPMorgan
02/12/21 SVB Leerink
Amicus downgraded to Market Perform from Outperform at SVB Leerink
PKI PerkinElmer
$126.38 /

+0.4 (+0.32%)

02/03/21 Citi
PerkinElmer price target raised to $155 from $150 at Citi
01/07/21 Piper Sandler
Oxford Immunotec downgraded to Neutral from Overweight at Piper Sandler
01/07/21 Wells Fargo
PerkinElmer upgraded to Overweight from Equal Weight at Wells Fargo
01/07/21 Wells Fargo
PerkinElmer upgraded to Overweight from Equal Weight at Wells Fargo
SRPT Sarepta
$84.92 /

+0.505 (+0.60%)

SNY Sanofi
$49.06 /

-0.33 (-0.67%)

SLDB Solid Biosciences
$6.67 /

+0.22 (+3.41%)

REGN Regeneron
$496.30 /

+14.06 (+2.92%)

PTCT PTC Therapeutics
$55.75 /

-1.98 (-3.43%)

PKI PerkinElmer
$126.38 /

+0.4 (+0.32%)

NVS Novartis
$85.74 /

-0.23 (-0.27%)

FOLD Amicus
$10.55 /

+0.06 (+0.57%)

DYN Dyne Therapeutics
$16.58 /

-0.055 (-0.33%)

CYTK Cytokinetics
$25.69 /

+1.87 (+7.85%)

CPRX Catalyst Pharmaceuticals
$4.22 /

+0.1 (+2.43%)

BIIB Biogen
$264.14 /

+4.36 (+1.68%)

BHVN Biohaven Pharmaceutical
$77.11 /

+1.39 (+1.84%)

ALXN Alexion
$153.23 /

-0.09 (-0.06%)

  • 19
    Mar
  • 16
    Mar
  • 21
    Jan
  • 29
    Sep
  • 17
    Sep
  • 17
    Jul
  • 27
    May
SNY Sanofi
$49.06 /

-0.33 (-0.67%)

REGN Regeneron
$496.30 /

+14.06 (+2.92%)

NVS Novartis
$85.74 /

-0.23 (-0.27%)

FOLD Amicus
$10.55 /

+0.06 (+0.57%)

BIIB Biogen
$264.14 /

+4.36 (+1.68%)

ALXN Alexion
$153.23 /

-0.09 (-0.06%)

SRPT Sarepta
$84.92 /

+0.505 (+0.60%)

SNY Sanofi
$49.06 /

-0.33 (-0.67%)

SLDB Solid Biosciences
$6.67 /

+0.22 (+3.41%)

REGN Regeneron
$496.30 /

+14.06 (+2.92%)

PTCT PTC Therapeutics
$55.75 /

-1.98 (-3.43%)

PKI PerkinElmer
$126.38 /

+0.4 (+0.32%)

ORPH Orphazyme
$12.75 /

-0.55 (-4.14%)

NVS Novartis
$85.74 /

-0.23 (-0.27%)

FOLD Amicus
$10.55 /

+0.06 (+0.57%)

DYN Dyne Therapeutics
$16.58 /

-0.055 (-0.33%)

CYTK Cytokinetics
$25.69 /

+1.87 (+7.85%)

CPRX Catalyst Pharmaceuticals
$4.22 /

+0.1 (+2.43%)

BIIB Biogen
$264.14 /

+4.36 (+1.68%)

ALXN Alexion
$153.23 /

-0.09 (-0.06%)

REGN Regeneron
$496.30 /

+14.06 (+2.92%)

FOLD Amicus
$10.55 /

+0.06 (+0.57%)

CYTK Cytokinetics
$25.69 /

+1.87 (+7.85%)

BIIB Biogen
$264.14 /

+4.36 (+1.68%)

ALXN Alexion
$153.23 /

-0.09 (-0.06%)

Conference/Events
Muscular Dystrophy Association to hold a virtual conference » 04:55
03/17/21
03/17
04:55
03/17/21
04:55
ALXN

Alexion

$153.32 /

+1.14 (+0.75%)

, SDNA

Sedona Corporation

$0.00 /

+ (+0.00%)

, BIIB

Biogen

$259.78 /

-0.37 (-0.14%)

, PTCT

PTC Therapeutics

$57.73 /

-0.3 (-0.52%)

, SRPT

Sarepta

$84.40 /

-1.39 (-1.62%)

, NVS

Novartis

$85.96 /

+0.66 (+0.77%)

, SNY

Sanofi

$49.40 /

+0.59 (+1.21%)

, SLDB

Solid Biosciences

$6.45 /

-3.115 (-32.58%)

, REGN

Regeneron

$482.31 /

-1.17 (-0.24%)

, BHVN

Biohaven Pharmaceutical

$75.72 /

-5.655 (-6.95%)

, ORPH

Orphazyme

$13.30 /

+0.84 (+6.74%)

, CPRX

Catalyst Pharmaceuticals

$4.12 /

+0.19 (+4.83%)

, DYN

Dyne Therapeutics

$16.62 /

-0.12 (-0.72%)

, CYTK

Cytokinetics

$23.85 /

-0.42 (-1.73%)

, FOLD

Amicus

$10.49 /

-0.28 (-2.60%)

, PKI

PerkinElmer

$125.97 /

-0.715 (-0.56%)

MDA Clinical &…

MDA Clinical & Scientific Virtual Conference 2021 will be held on March 14-18. Webcast Link

ShowHide Related Items >><<
SRPT Sarepta
$84.40 /

-1.39 (-1.62%)

SNY Sanofi
$49.40 /

+0.59 (+1.21%)

SLDB Solid Biosciences
$6.45 /

-3.115 (-32.58%)

REGN Regeneron
$482.31 /

-1.17 (-0.24%)

PTCT PTC Therapeutics
$57.73 /

-0.3 (-0.52%)

PKI PerkinElmer
$125.97 /

-0.715 (-0.56%)

ORPH Orphazyme
$13.30 /

+0.84 (+6.74%)

NVS Novartis
$85.96 /

+0.66 (+0.77%)

FOLD Amicus
$10.49 /

-0.28 (-2.60%)

DYN Dyne Therapeutics
$16.62 /

-0.12 (-0.72%)

CYTK Cytokinetics
$23.85 /

-0.42 (-1.73%)

CPRX Catalyst Pharmaceuticals
$4.12 /

+0.19 (+4.83%)

BIIB Biogen
$259.78 /

-0.37 (-0.14%)

BHVN Biohaven Pharmaceutical
$75.72 /

-5.655 (-6.95%)

ALXN Alexion
$153.32 /

+1.14 (+0.75%)

ALXN Alexion
$153.32 /

+1.14 (+0.75%)

02/04/21 Piper Sandler
Alexion downgraded to Neutral ahead of expected deal closing at Piper Sandler
02/04/21 Piper Sandler
Alexion downgraded to Neutral from Overweight at Piper Sandler
01/08/21 Raymond James
Alexion downgraded to Market Perform from Outperform at Raymond James
12/16/20 Truist
Alexion downgraded to Hold from Buy at Truist
SDNA Sedona Corporation
$0.00 /

+ (+0.00%)

BIIB Biogen
$259.78 /

-0.37 (-0.14%)

02/17/21 Cantor Fitzgerald
Biogen price target lowered to $268 from $278 at Cantor Fitzgerald
02/08/21 Citi
Expert sees Biogen aducanumab approval 50/50 at best, says Citi
02/04/21 SVB Leerink
Biogen price target lowered to $380 from $430 at SVB Leerink
02/04/21 Credit Suisse
Biogen price target lowered to $338 from $350 at Credit Suisse
PTCT PTC Therapeutics
$57.73 /

-0.3 (-0.52%)

02/26/21 Cantor Fitzgerald
PTC Therapeutics price target lowered to $75 from $81 at Cantor Fitzgerald
02/12/21 BofA
PTC Therapeutics downgraded to Neutral from Buy at BofA
02/12/21 BofA
PTC Therapeutics downgraded to Neutral from Buy at BofA
01/05/21 Citi
PTC Therapeutics upgraded to Buy from Neutral at Citi
SRPT Sarepta
$84.40 /

-1.39 (-1.62%)

03/02/21 RBC Capital
Sarepta price target lowered to $132 from $143 at RBC Capital
03/02/21 Piper Sandler
Sarepta price target lowered to $130 from $140 at Piper Sandler
02/26/21 Mizuho
Sarepta price target raised to $160 from $158 at Mizuho
02/25/21 Piper Sandler
Piper says Sarepta's Amondys 45 approval comes with 'relatively clean label'
NVS Novartis
$85.96 /

+0.66 (+0.77%)

03/10/21
Fly Intel: Top five analyst downgrades
03/10/21 Argus
Novartis cut to Hold at Argus on slowing top-line growth, greater competition
03/10/21 Argus
Novartis downgraded to Hold from Buy at Argus
03/01/21 Oppenheimer
Homology Medicines loses potential source of upside, says Oppenheimer
SNY Sanofi
$49.40 /

+0.59 (+1.21%)

02/23/21 BofA
BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list
02/10/21 Morgan Stanley
Sanofi price target raised to EUR 104 from EUR 101 at Morgan Stanley
02/05/21 Piper Sandler
Piper reiterates Overweight on Kymera after Sanofi capital markets day
01/19/21 UBS
Sanofi price target lowered to EUR 99 from EUR 100 at UBS
SLDB Solid Biosciences
$6.45 /

-3.115 (-32.58%)

03/16/21 Chardan
Solid Biosciences price target raised to $20 from $12.50 at Chardan
03/16/21
Fly Intel: Top five analyst upgrades
03/16/21 SVB Leerink
Solid Biosciences upgraded to Outperform at SVB Leerink
03/16/21 SVB Leerink
Solid Biosciences upgraded to Outperform from Market Perform at SVB Leerink
REGN Regeneron
$482.31 /

-1.17 (-0.24%)

03/11/21 Evercore ISI
Kodiak Sciences initiated with an Outperform at Evercore ISI
03/11/21 Needham
Vir Biotechnology price target raised to $80 from $75 at Needham
02/23/21 Credit Suisse
Regeneron price target raised to $760 from $753 at Credit Suisse
02/16/21 Cantor Fitzgerald
Regeneron price target lowered to $656 from $696 at Cantor Fitzgerald
BHVN Biohaven Pharmaceutical
$75.72 /

-5.655 (-6.95%)

03/11/21
Fly Intel: Top five analyst initiations
03/11/21 UBS
Biohaven Pharmaceutical initiated with a Buy at UBS
03/02/21 Mizuho
Biohaven Pharmaceutical price target raised to $103 from $93 at Mizuho
03/01/21 Piper Sandler
Biohaven price target raised to $110 from $90 at Piper Sandler
ORPH Orphazyme
$13.30 /

+0.84 (+6.74%)

10/26/20 Guggenheim
Orphazyme initiated with a Buy at Guggenheim
10/26/20 BofA
Orphazyme initiated with a Buy at BofA
10/26/20 BofA
Orphazyme initiated with a Buy at BofA
CPRX Catalyst Pharmaceuticals
$4.12 /

+0.19 (+4.83%)

03/16/21 Piper Sandler
Catalyst business continues to generate cash flow, says Piper Sandler
01/07/21 Piper Sandler
Piper says Catalyst's Firdapse commercial business performing as expected
01/06/21 Piper Sandler
Catalyst Firdapse commercial business performing as expected, says Piper Sandler
11/10/20 Piper Sandler
Catalyst Pharmaceuticals price target lowered to $5.50 from $6 at Piper Sandler
DYN Dyne Therapeutics
$16.62 /

-0.12 (-0.72%)

03/05/21 Stifel
Dyne Therapeutics weakness a buying opportunity, says Stifel
02/09/21
Dyne Therapeutics initiated with a Buy at JonesTrading
01/07/21 Piper Sandler
Dyne Therapeutics potential beneficiary of Sarepta's SRP-9001 miss, says Piper
10/12/20 Jefferies
Dyne Therapeutics initiated with a Buy at Jefferies
CYTK Cytokinetics
$23.85 /

-0.42 (-1.73%)

03/11/21 Wolfe Research
Cytokinetics initiated with an Outperform at Wolfe Research
02/18/21 Barclays
Cytokinetics initiated with an Overweight at Barclays
01/20/21 H.C. Wainwright
Cytokinetics price target raised to $41 from $22 at H.C. Wainwright
12/28/20 Oppenheimer
Amgen price target lowered to $266 from $274 at Oppenheimer
FOLD Amicus
$10.49 /

-0.28 (-2.60%)

03/01/21 Stifel
Amicus initiated with a Hold at Stifel
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 JPMorgan
Amicus downgraded to Neutral on Pompe disease miss at JPMorgan
02/12/21 SVB Leerink
Amicus downgraded to Market Perform from Outperform at SVB Leerink
PKI PerkinElmer
$125.97 /

-0.715 (-0.56%)

02/03/21 Citi
PerkinElmer price target raised to $155 from $150 at Citi
01/07/21 Piper Sandler
Oxford Immunotec downgraded to Neutral from Overweight at Piper Sandler
01/07/21 Wells Fargo
PerkinElmer upgraded to Overweight from Equal Weight at Wells Fargo
01/07/21 Wells Fargo
PerkinElmer upgraded to Overweight from Equal Weight at Wells Fargo
SRPT Sarepta
$84.40 /

-1.39 (-1.62%)

SNY Sanofi
$49.40 /

+0.59 (+1.21%)

SLDB Solid Biosciences
$6.45 /

-3.115 (-32.58%)

REGN Regeneron
$482.31 /

-1.17 (-0.24%)

PTCT PTC Therapeutics
$57.73 /

-0.3 (-0.52%)

PKI PerkinElmer
$125.97 /

-0.715 (-0.56%)

NVS Novartis
$85.96 /

+0.66 (+0.77%)

FOLD Amicus
$10.49 /

-0.28 (-2.60%)

DYN Dyne Therapeutics
$16.62 /

-0.12 (-0.72%)

CYTK Cytokinetics
$23.85 /

-0.42 (-1.73%)

CPRX Catalyst Pharmaceuticals
$4.12 /

+0.19 (+4.83%)

BIIB Biogen
$259.78 /

-0.37 (-0.14%)

BHVN Biohaven Pharmaceutical
$75.72 /

-5.655 (-6.95%)

ALXN Alexion
$153.32 /

+1.14 (+0.75%)

  • 16
    Mar
  • 21
    Jan
  • 29
    Sep
  • 17
    Sep
  • 17
    Jul
  • 27
    May
SNY Sanofi
$49.40 /

+0.59 (+1.21%)

REGN Regeneron
$482.31 /

-1.17 (-0.24%)

NVS Novartis
$85.96 /

+0.66 (+0.77%)

FOLD Amicus
$10.49 /

-0.28 (-2.60%)

BIIB Biogen
$259.78 /

-0.37 (-0.14%)

ALXN Alexion
$153.32 /

+1.14 (+0.75%)

SRPT Sarepta
$84.40 /

-1.39 (-1.62%)

SNY Sanofi
$49.40 /

+0.59 (+1.21%)

SLDB Solid Biosciences
$6.45 /

-3.115 (-32.58%)

REGN Regeneron
$482.31 /

-1.17 (-0.24%)

PTCT PTC Therapeutics
$57.73 /

-0.3 (-0.52%)

PKI PerkinElmer
$125.97 /

-0.715 (-0.56%)

ORPH Orphazyme
$13.30 /

+0.84 (+6.74%)

NVS Novartis
$85.96 /

+0.66 (+0.77%)

FOLD Amicus
$10.49 /

-0.28 (-2.60%)

DYN Dyne Therapeutics
$16.62 /

-0.12 (-0.72%)

CYTK Cytokinetics
$23.85 /

-0.42 (-1.73%)

CPRX Catalyst Pharmaceuticals
$4.12 /

+0.19 (+4.83%)

BIIB Biogen
$259.78 /

-0.37 (-0.14%)

ALXN Alexion
$153.32 /

+1.14 (+0.75%)

REGN Regeneron
$482.31 /

-1.17 (-0.24%)

FOLD Amicus
$10.49 /

-0.28 (-2.60%)

CYTK Cytokinetics
$23.85 /

-0.42 (-1.73%)

BIIB Biogen
$259.78 /

-0.37 (-0.14%)

ALXN Alexion
$153.32 /

+1.14 (+0.75%)

Conference/Events
Muscular Dystrophy Association to hold a virtual conference » 04:55
03/17/21
03/17
04:55
03/17/21
04:55
ALXN

Alexion

$153.32 /

+1.14 (+0.75%)

, BHVN

Biohaven Pharmaceutical

$75.72 /

-5.655 (-6.95%)

, BIIB

Biogen

$259.78 /

-0.37 (-0.14%)

, CPRX

Catalyst Pharmaceuticals

$4.12 /

+0.19 (+4.83%)

, CYTK

Cytokinetics

$23.85 /

-0.42 (-1.73%)

, DYN

Dyne Therapeutics

$16.62 /

-0.12 (-0.72%)

, FOLD

Amicus

$10.49 /

-0.28 (-2.60%)

, NVS

Novartis

$85.96 /

+0.66 (+0.77%)

, ORPH

Orphazyme

$13.30 /

+0.84 (+6.74%)

, PKI

PerkinElmer

$125.97 /

-0.715 (-0.56%)

, PTCT

PTC Therapeutics

$57.73 /

-0.3 (-0.52%)

, REGN

Regeneron

$482.31 /

-1.17 (-0.24%)

, SLDB

Solid Biosciences

$6.45 /

-3.115 (-32.58%)

, SNY

Sanofi

$49.40 /

+0.59 (+1.21%)

, SRPT

Sarepta

$84.40 /

-1.39 (-1.62%)

MDA Clinical &…

MDA Clinical & Scientific Virtual Conference 2021 will be held on March 14-18. Webcast Link

ShowHide Related Items >><<
SRPT Sarepta
$84.40 /

-1.39 (-1.62%)

SNY Sanofi
$49.40 /

+0.59 (+1.21%)

SLDB Solid Biosciences
$6.45 /

-3.115 (-32.58%)

REGN Regeneron
$482.31 /

-1.17 (-0.24%)

PTCT PTC Therapeutics
$57.73 /

-0.3 (-0.52%)

PKI PerkinElmer
$125.97 /

-0.715 (-0.56%)

ORPH Orphazyme
$13.30 /

+0.84 (+6.74%)

NVS Novartis
$85.96 /

+0.66 (+0.77%)

FOLD Amicus
$10.49 /

-0.28 (-2.60%)

DYN Dyne Therapeutics
$16.62 /

-0.12 (-0.72%)

CYTK Cytokinetics
$23.85 /

-0.42 (-1.73%)

CPRX Catalyst Pharmaceuticals
$4.12 /

+0.19 (+4.83%)

BIIB Biogen
$259.78 /

-0.37 (-0.14%)

BHVN Biohaven Pharmaceutical
$75.72 /

-5.655 (-6.95%)

ALXN Alexion
$153.32 /

+1.14 (+0.75%)

ALXN Alexion
$153.32 /

+1.14 (+0.75%)

02/04/21 Piper Sandler
Alexion downgraded to Neutral ahead of expected deal closing at Piper Sandler
02/04/21 Piper Sandler
Alexion downgraded to Neutral from Overweight at Piper Sandler
01/08/21 Raymond James
Alexion downgraded to Market Perform from Outperform at Raymond James
12/16/20 Truist
Alexion downgraded to Hold from Buy at Truist
BHVN Biohaven Pharmaceutical
$75.72 /

-5.655 (-6.95%)

03/11/21
Fly Intel: Top five analyst initiations
03/11/21 UBS
Biohaven Pharmaceutical initiated with a Buy at UBS
03/02/21 Mizuho
Biohaven Pharmaceutical price target raised to $103 from $93 at Mizuho
03/01/21 Piper Sandler
Biohaven price target raised to $110 from $90 at Piper Sandler
BIIB Biogen
$259.78 /

-0.37 (-0.14%)

02/17/21 Cantor Fitzgerald
Biogen price target lowered to $268 from $278 at Cantor Fitzgerald
02/08/21 Citi
Expert sees Biogen aducanumab approval 50/50 at best, says Citi
02/04/21 SVB Leerink
Biogen price target lowered to $380 from $430 at SVB Leerink
02/04/21 Credit Suisse
Biogen price target lowered to $338 from $350 at Credit Suisse
CPRX Catalyst Pharmaceuticals
$4.12 /

+0.19 (+4.83%)

03/16/21 Piper Sandler
Catalyst business continues to generate cash flow, says Piper Sandler
01/07/21 Piper Sandler
Piper says Catalyst's Firdapse commercial business performing as expected
01/06/21 Piper Sandler
Catalyst Firdapse commercial business performing as expected, says Piper Sandler
11/10/20 Piper Sandler
Catalyst Pharmaceuticals price target lowered to $5.50 from $6 at Piper Sandler
CYTK Cytokinetics
$23.85 /

-0.42 (-1.73%)

03/11/21 Wolfe Research
Cytokinetics initiated with an Outperform at Wolfe Research
02/18/21 Barclays
Cytokinetics initiated with an Overweight at Barclays
01/20/21 H.C. Wainwright
Cytokinetics price target raised to $41 from $22 at H.C. Wainwright
12/28/20 Oppenheimer
Amgen price target lowered to $266 from $274 at Oppenheimer
DYN Dyne Therapeutics
$16.62 /

-0.12 (-0.72%)

03/05/21 Stifel
Dyne Therapeutics weakness a buying opportunity, says Stifel
02/09/21
Dyne Therapeutics initiated with a Buy at JonesTrading
01/07/21 Piper Sandler
Dyne Therapeutics potential beneficiary of Sarepta's SRP-9001 miss, says Piper
10/12/20 Jefferies
Dyne Therapeutics initiated with a Buy at Jefferies
FOLD Amicus
$10.49 /

-0.28 (-2.60%)

03/01/21 Stifel
Amicus initiated with a Hold at Stifel
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 JPMorgan
Amicus downgraded to Neutral on Pompe disease miss at JPMorgan
02/12/21 SVB Leerink
Amicus downgraded to Market Perform from Outperform at SVB Leerink
NVS Novartis
$85.96 /

+0.66 (+0.77%)

03/10/21
Fly Intel: Top five analyst downgrades
03/10/21 Argus
Novartis cut to Hold at Argus on slowing top-line growth, greater competition
03/10/21 Argus
Novartis downgraded to Hold from Buy at Argus
03/01/21 Oppenheimer
Homology Medicines loses potential source of upside, says Oppenheimer
ORPH Orphazyme
$13.30 /

+0.84 (+6.74%)

10/26/20 Guggenheim
Orphazyme initiated with a Buy at Guggenheim
10/26/20 BofA
Orphazyme initiated with a Buy at BofA
10/26/20 BofA
Orphazyme initiated with a Buy at BofA
PKI PerkinElmer
$125.97 /

-0.715 (-0.56%)

02/03/21 Citi
PerkinElmer price target raised to $155 from $150 at Citi
01/07/21 Piper Sandler
Oxford Immunotec downgraded to Neutral from Overweight at Piper Sandler
01/07/21 Wells Fargo
PerkinElmer upgraded to Overweight from Equal Weight at Wells Fargo
01/07/21 Wells Fargo
PerkinElmer upgraded to Overweight from Equal Weight at Wells Fargo
PTCT PTC Therapeutics
$57.73 /

-0.3 (-0.52%)

02/26/21 Cantor Fitzgerald
PTC Therapeutics price target lowered to $75 from $81 at Cantor Fitzgerald
02/12/21 BofA
PTC Therapeutics downgraded to Neutral from Buy at BofA
02/12/21 BofA
PTC Therapeutics downgraded to Neutral from Buy at BofA
01/05/21 Citi
PTC Therapeutics upgraded to Buy from Neutral at Citi
REGN Regeneron
$482.31 /

-1.17 (-0.24%)

03/11/21 Evercore ISI
Kodiak Sciences initiated with an Outperform at Evercore ISI
03/11/21 Needham
Vir Biotechnology price target raised to $80 from $75 at Needham
02/23/21 Credit Suisse
Regeneron price target raised to $760 from $753 at Credit Suisse
02/16/21 Cantor Fitzgerald
Regeneron price target lowered to $656 from $696 at Cantor Fitzgerald
SLDB Solid Biosciences
$6.45 /

-3.115 (-32.58%)

03/16/21 Chardan
Solid Biosciences price target raised to $20 from $12.50 at Chardan
03/16/21
Fly Intel: Top five analyst upgrades
03/16/21 SVB Leerink
Solid Biosciences upgraded to Outperform at SVB Leerink
03/16/21 SVB Leerink
Solid Biosciences upgraded to Outperform from Market Perform at SVB Leerink
SNY Sanofi
$49.40 /

+0.59 (+1.21%)

02/23/21 BofA
BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list
02/10/21 Morgan Stanley
Sanofi price target raised to EUR 104 from EUR 101 at Morgan Stanley
02/05/21 Piper Sandler
Piper reiterates Overweight on Kymera after Sanofi capital markets day
01/19/21 UBS
Sanofi price target lowered to EUR 99 from EUR 100 at UBS
SRPT Sarepta
$84.40 /

-1.39 (-1.62%)

03/02/21 RBC Capital
Sarepta price target lowered to $132 from $143 at RBC Capital
03/02/21 Piper Sandler
Sarepta price target lowered to $130 from $140 at Piper Sandler
02/26/21 Mizuho
Sarepta price target raised to $160 from $158 at Mizuho
02/25/21 Piper Sandler
Piper says Sarepta's Amondys 45 approval comes with 'relatively clean label'
SRPT Sarepta
$84.40 /

-1.39 (-1.62%)

SNY Sanofi
$49.40 /

+0.59 (+1.21%)

SLDB Solid Biosciences
$6.45 /

-3.115 (-32.58%)

REGN Regeneron
$482.31 /

-1.17 (-0.24%)

PTCT PTC Therapeutics
$57.73 /

-0.3 (-0.52%)

PKI PerkinElmer
$125.97 /

-0.715 (-0.56%)

NVS Novartis
$85.96 /

+0.66 (+0.77%)

FOLD Amicus
$10.49 /

-0.28 (-2.60%)

DYN Dyne Therapeutics
$16.62 /

-0.12 (-0.72%)

CYTK Cytokinetics
$23.85 /

-0.42 (-1.73%)

CPRX Catalyst Pharmaceuticals
$4.12 /

+0.19 (+4.83%)

BIIB Biogen
$259.78 /

-0.37 (-0.14%)

BHVN Biohaven Pharmaceutical
$75.72 /

-5.655 (-6.95%)

ALXN Alexion
$153.32 /

+1.14 (+0.75%)

  • 16
    Mar
  • 21
    Jan
  • 29
    Sep
  • 17
    Sep
  • 17
    Jul
  • 27
    May
SNY Sanofi
$49.40 /

+0.59 (+1.21%)

REGN Regeneron
$482.31 /

-1.17 (-0.24%)

NVS Novartis
$85.96 /

+0.66 (+0.77%)

FOLD Amicus
$10.49 /

-0.28 (-2.60%)

BIIB Biogen
$259.78 /

-0.37 (-0.14%)

ALXN Alexion
$153.32 /

+1.14 (+0.75%)

SRPT Sarepta
$84.40 /

-1.39 (-1.62%)

SNY Sanofi
$49.40 /

+0.59 (+1.21%)

SLDB Solid Biosciences
$6.45 /

-3.115 (-32.58%)

REGN Regeneron
$482.31 /

-1.17 (-0.24%)

PTCT PTC Therapeutics
$57.73 /

-0.3 (-0.52%)

PKI PerkinElmer
$125.97 /

-0.715 (-0.56%)

ORPH Orphazyme
$13.30 /

+0.84 (+6.74%)

NVS Novartis
$85.96 /

+0.66 (+0.77%)

FOLD Amicus
$10.49 /

-0.28 (-2.60%)

DYN Dyne Therapeutics
$16.62 /

-0.12 (-0.72%)

CYTK Cytokinetics
$23.85 /

-0.42 (-1.73%)

CPRX Catalyst Pharmaceuticals
$4.12 /

+0.19 (+4.83%)

BIIB Biogen
$259.78 /

-0.37 (-0.14%)

ALXN Alexion
$153.32 /

+1.14 (+0.75%)

REGN Regeneron
$482.31 /

-1.17 (-0.24%)

FOLD Amicus
$10.49 /

-0.28 (-2.60%)

CYTK Cytokinetics
$23.85 /

-0.42 (-1.73%)

BIIB Biogen
$259.78 /

-0.37 (-0.14%)

ALXN Alexion
$153.32 /

+1.14 (+0.75%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.